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ABSTRACT 
 
 
Near-infrared (NIR) light, with wavelengths of 650 to 900 nanometers, effectively 
penetrates tissues. The high signal to noise ratio and low phototoxicity of NIR light 
makes this wavelength range ideal for deep tissue imaging. However, current NIR 
fluorophores are generally large hydrophobic molecules that are prone to aggregation. 
Sulfonation can enhance aqueous solubility, but their anionic nature prevents membrane 
diffusion, and thus, restricts the applications of sulfonated molecules to in vitro or fixed 
cells.  
 
The repertoire of commercially available sulfonated NIR probes is mostly limited 
cyanines, which have low photostability. Moreover, larger cyanines require multiple 
sulfonates to maintain aqueous solubility. For example, Indocyanine Green is only 
sparingly soluble in PBS, despite having two sulfonates.  
 
My work has focused on the delivery of sulfonated dyes into live cells and the 
development of a new, ultra-compact NIR dye scaffold. First, to expand the in-cell 
applications of sulfonated fluorophores, I designed reductively-labile sulfonate protecting 
groups. Using these scaffolds, I have successfully delivered the fluorophore dansyl 
sulfonate into live cells, where the cytosolic reducing environment unmasks the anionic 
sulfonate. Secondly, to create a compact, photostable NIR fluorophore, I pioneered the 
discovery of azasilines dyes. The two azasiline derivatives, ASiFluor710 and 
ASiFluor730, fluoresce over 700 nanometers and are among the most compact NIR 
v 
 
fluorophores currently known. ASiFluor730 also retains the high photostability of 
oxazine dyes, highlighting their potential in long exposure applications. Beyond the 
immediate applications in fluorescence microscopy and in vivo imaging, I envision that 
my work will serve as a framework for the future design of soluble, membrane 
permeable, NIR fluorescent probes. 
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Fluorescence 
 
Fluorescence is the optical phenomenon whereby a molecule becomes excited via 
photon absorption and relaxes via photon emission. Generally, the energy of the photon 
absorbed is higher than the one released.1 However, a fluorescent molecule can also 
become excited when it absorbs two lower energy photons, a process known as two-
photon absorption, where each photon is roughly half the energy needed to excite the 
molecule. The energy of the photon can be calculated with the Planck-Einstein relation 
(Eq. 1.1). According to the equation, wave frequency (𝑣) is proportional to energy (𝐸) 
and inversely proportional to the wavelength (λ) of the photon, where ℎ and c are 
Planck’s constant and the speed of light, respectively. That is, the longer the wavelength, 
the lower the energy. For example, fluorescein has a peak absorption (a.k.a. excitation, 
λex) wavelength of  491 nm (2.5 eV) and  a peak emission (λem) wavelength  of 515 nm 
(2.4 eV).2  
 
𝐸 = ℎ𝑣 =
ℎc
λ
  [Eq. 1.1] 
 
The main steps of fluorescence can be illustrated using a Jablonski diagram 
(Figure 1.1). When a fluorophore becomes excited, an electron is promoted from the 
ground state (S0) to an excited state (S1, S2, S3, etc). Once excited, the electron 
equilibrates to the lowest vibrational energy level of S1. An electron already in the S1 
state can simply relax to the lowest S1 vibrational level via vibrational relaxation. An 
 3 
 
 
electron in a higher excited state such as S2 must first relax via vibrational relaxation to 
an energy level that overlaps with S1, and then enter S1 via internal conversion. From S1, 
the electron finally relaxes back to S0 by emitting a photon, a process known as radiative 
relaxation (fluorescence). Energy is dissipated during vibrational relaxation prior to 
emission, thus the energy of the emitted photon is always lower than the photon 
absorbed. In the case of two-photon excitation, the energy of the emitted photon is always 
less than the combined energies of the photons absorbed. 
 
Instead of radiative relaxation, which gives rise to fluorescence, the electron in S1 
can also enter a triplet state (T1), by a process called intersystem crossing. Like internal 
conversion, intersystem crossing is possible between S1 and T1 states with overlapping 
energies. However, the rate of intersystem crossing is magnitudes lower than internal 
conversion because it is spin forbidden and thus, requires spin conversion (flip). An 
electron in T1 can relax to S0 via radiative relaxation (phosphorescence) if another spin 
conversion occurs. Since two rate-limiting spin conversions are required, the radiative 
rate of phosphorescence is much lower than fluorescence. 
 
Most molecules are in a singlet state and do not interact with diatomic oxygen (3O2), 
which is in a triplet state. However, triplet state molecules can interact with 3O2 to form 
singlet state oxygen (1O2) and other oxygen species (ROS) via energy transfer. The 
generated ROS can, in turn, interact with and destroy the fluorophore (photobleaching) or 
induce phototoxicity, a property that has been exploited in photodynamic therapy 
(PDT).1,3–6  
 4 
 
 
 
 
Figure 1.1: Jablonski diagram. Absorption of a photon excites the fluorophore, 
promoting an electron from S0 to and an excited state (Sx) (blue arrow). An electron from 
a higher excited state (i.e S2) can enter S1 through internal conversion and then relax to 
the lowest vibrational level of S1 via vibrational relaxation (black dashed arrows). From 
S1, the electron can either relax back to S0 via radiative relaxation (green arrow, 
fluorescence) or enter the triplet state T1 via intersystem crossing. In T1, the electron 
either relaxes back to S0 via radiative relaxation (red arrow, phosphorescence) or undergo 
energy transfer with triplet state oxygen (3O2) to form singlet state oxygen (1O2). 
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A fluorophore has several important photophysical characteristics: peak excitation 
and emission wavelengths, molar extinction coefficient, fluorescent lifetime, and 
quantum yield. As discussed previously, due to energy losses during vibration relaxation, 
the energy required for excitation is always higher than the energy of the photon emitted. 
This energy difference is reflected by the difference between the peak excitation (λex) and 
emission (λem) wavelengths in nanometers, known as the Stokes’ shift (λex - λem). For 
example, the Stokes’ shift of fluorescein is 24 nm (515-491) (Figure 1.2). The molar 
extinction coefficient (ε) measures how well the fluorophore absorbs photons. 
Fluorescence lifetime (tfl) describes how long the fluorophore remains in the excited state 
before photon emission. Lastly, the fluorescence quantum yield (Φfl) measures how 
efficiently the fluorophore reemits a photon.  
 
A simple view of the Φfl is the ratio of photons emitted over photons absorbed (Eq. 
1.2). For example, if a fluorophore absorbs 100 photons and in turn, reemits 100 photons, 
then the Φfl = 1 or 100% (100/100 = 1). Conversely, if a fluorophore absorbs 100 photons 
and in turn, reemits only 50 photons, then the Φfl becomes 0.5 (50/100 = 0.5). 
Accordingly, a non-emitting molecule has a Φfl of 0 (0/100 = 0).  
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Figure 1.2: Optical properties of fluorescein. Absorption (red), emission (blue), 
Stokes’ shift (black) and structure (top) of fluorescein 
 
 
 
 
Φfl =
𝑝ℎ𝑜𝑡𝑜𝑛𝑠 𝑒𝑚𝑖𝑡𝑡𝑒𝑑
𝑝ℎ𝑜𝑡𝑜𝑛𝑠 𝑎𝑏𝑠𝑜𝑟𝑏𝑒𝑑
   [Eq. 1.2] 
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Fluorescence in Biology 
 
Chemical fluorescent probes or fluorophores are heavily utilized to elucidate key 
biological processes as well as to visualize structural morphology. These light emitting 
molecules allow us to noninvasively visualize, locate and identify biological targets with 
great detail.7 They are extremely versatile, having found important roles in both research 
and clinical settings.8,9 Popular examples of fluorescence-based techniques include: ion 
sensing, enzyme-linked immunosorbent assay (ELISA), and fluorescence microscopy. 
 
Fluorescent-based probes have been widely used as sensors to detect ion flux. 
Binding of the sensor to its orthogonal target will either lead to activation or inhibition 
(quenching) of fluorescence.10–12 For example, Calcein AM, Fura-2, and Indo-1 are three 
popular calcium sensors (Figure 1.3). Although they are all calcium sensors, their 
underlying mechanisms are different. Calcein AM is a single wavelength sensor, where 
calcium binding increases the fluorescence. In contrast, Fura-2 and Indo-1 are ratiometric 
sensors, meaning that calcium-binding changes their spectral profiles. For Fura-2, 
calcium binding shifts the absorption spectra (from 340 to 380 nm), while maintaining 
the same peak emission wavelength. Calcium concentration is calculated by the ratio of 
emission signals from 340 nm and 380 nm excitation. Calcium binding to Indo-1 shifts 
the peak emission from 340 to 300 nm and the concentration of calcium is calculated by 
the ratio of two emission signals.13  
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Figure 1.3: Examples of chemical sensors 
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ELISA utilizes enzyme-conjugated antibodies to detect proteins of interest. 
Traditional ELISA was chemiluminescence-based, however, fluorescence-based assays 
predominate in modern applications. In an ELISA assay, samples are treated with 
primary antibodies to detect a specific protein of interest, followed by an enzyme linked-
secondary antibody that recognizes the primary antibody. The enzyme on the secondary 
antibody then acts on a fluorophore precursor (leuco-dye) to generate the active 
fluorophore allowing for instrumental detection.   
 
Fluorescence microscopy can be performed on either fixed or live cells (Figure 1.4). 
Fixed cells offer a convenient way to detect specific proteins and selectively image 
structures of interest using fluorescently labeled antibodies, a technique known as 
immunofluorescence microscopy.14 Live cells offer a more realistic image of cellular 
dynamics and physiology, but this procedure is usually limited to the usage of fluorescent 
proteins. Antibodies simply cannot diffuse across cellular membranes. Although site-
specific antibodies aren’t suitable for live cells, there are a plethora of fluorescent 
markers. These fluorescent markers are specially designed to identify and survey specific 
subcellular compartments in cells. For example, commercially available ERTracker, 
MitoTracker, LysoTracker, and DRAQ5 are designed to accumulate in the endoplasmic 
reticulum (ER), mitochondria, lysosomes, and nucleus, respectively.15–19 Moreover, ion 
sensors such as Calcein AM and others can be used in live-cell imaging to monitor ion 
flux. Finally, applications of fluorophores are not confined to research settings. For 
example, fluorescein is used as a beacon to guide rescuers to the site of distress during 
 10 
 
 
sea rescues and to detect physical damage of the cornea. Clearly, fluorescent probes have 
widespread applications, which will continue to expand.  
 
a)                        b)  
          
Figure 1.4: Fixed and live cell fluorescent staining. Actin stained with Alexa Fluor 633 
conjugated phalloidin in fixed Indian Muntjac deerskin fibroblast cells. Image is adopted 
from https://www.microscopyu.com/gallery-images/indian-muntjac-actin-cytoskeleton. 
(a) Live Hela cells stained with ER-Tracker (b). 
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Near Infrared (NIR) Fluorophores 
 
Visible-light fluorophores (400 – 650 nm) are compatible with a wide range of 
applications as previously mentioned. However, the employment and detection of visible 
light in biological samples can be problematic. First, endogenous chromophores typically 
absorb between 240 and 500 nm and emit (autofluorescent) between and 280 and 570 nm 
(Figure 1.5a). Other components include chlorophyll, which can absorb and emit at 
much longer wavelengths, and hemoglobin, which strongly absorbs light up to 700 nm 
(Figure 1.5b)4,20–22 Under many experimental conditions, visible-light fluorophores such 
as fluorescein and rhodamines are bright enough to overcome the background, however, 
these fluorophores may be inadequate for assays that require low fluorophore loading. 
Second, short wavelength illumination can excite endogenous chromophores and induce 
the formation of reactive oxygen species (ROS) leading to cytotoxicity or cell death 
(phototoxicity).23–26 Third, since hemoglobin strongly absorbs light up to 700 nm, in vivo 
deep tissue imaging with visible fluorophore is challenging (Figure 1.5).  
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a)                    b) 
      
 
Figure 1.5: Autofluorescence and absorption of endogenous chromophores.  
Emission of riboflavin (black), NADH (green), folic acid (red), cholecalciferol (purple), 
pyridoxine (tan) and retinol (orange) (a). Figure adopted from Zipfel et al.21 Hemoglobin 
strongly absorbs up to 700 nm. NIR light effectively penetrates deep tissues, giving 
higher fluorescence signal (b) Figure adopted from Weissleder et al.22 
 
 
 
 
The employment of near-infrared (NIR) fluorophores can circumvent many of the 
disadvantages of visible-light fluorophores. NIR light (650 - 900 nm) can more 
effectively penetrate deep tissues and avoid the excitation of most endogenous 
chromophores.27 Samples imaged with NIR probes are optically clearer compared to their 
visible-light counterparts and thus, more effective in cell and deep tissue imaging (Figure 
1.5).22 NIR fluorophores can also complement the wide palette of visible-light fluorescent 
probes with little or no spectral overlap. However, these major benefits are countered by 
several major drawbacks to NIR fluorophores. First, most NIR fluorophores have 
hyperextended π-conjugation, yielding planar compounds that are prone to self-
quenching via hydrophobic stacking and nonspecific binding.28 Second, quantum yields 
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of NIR fluorophores are typically lower than those of visible-light fluorophores.2,29,30 
Third, the diversity of NIR scaffolds remains scarce. Currently, the popular NIR 
fluorophore scaffolds include cyanines, squaraines, and boron-dipyrromethenes 
(BODIPYs) (Figure 1.6).31,32 
 
              
Figure 1.6: Structures of popular classes of NIR fluorophores 
 
 
 
 
Cyanines are by far the most popular class of NIR fluorophores and dominate the 
commercial markets. The most well-known cyanine derivative is perhaps Indocyanine 
Green (ICG), one of the three FDA approved imaging probes approved for human use 
(Figure 1.7).27,33 The excitation and emission wavelengths of cyanine dyes can be readily 
fine-tuned through the length of their polymethine chain. Moreover, cyanines have two 
nitrogens that can be functionalized with labeling moieties (Figure 1.8). Cyanines 
typically require 5 or more carbons within the polymethine chain to achieve NIR 
excitation/emission wavelengths. However, the polymethine chain is a hydrophobic 
planar structure that is part of the conjugated aromatic system. Thus, as the chain length 
increases, aqueous solubility, in turn, decreases. 
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Figure 1.7: Structure of Indocyanine Green (ICG) 
 
 
 
 
Negatively charged functional groups such as sulfonates (SO3-) are frequently used 
to endow aqueous solubility to hydrophobic molecules for reasons that will be discussed 
in the following section. The introduction of sulfonates greatly enhances the aqueous 
solubility and quantum yield of cyanines in water.34 However, large cyanines, such as 
ICG, even bis-sulfonation (two sulfonates) is not enough to grant complete aqueous 
solubility (Figure 1.7). In contrast to unsulfonated cyanines, most sulfonated cyanines 
cannot diffuse across the membrane of cells. The poor photostability of NIR cyanines 
also remains a critical weakness. Interestingly, due to their ability to generate singlet 
oxygen, which is related to the lack of photostability, cyanines are currently being 
evaluated as potential candidates for PDT.35,36 
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Figure 1.8: Excitation and emission of different cyanines. The length of polymethine 
chain determines the ex/em wavelengths of cyanines. Nitrogens of the indoline moiety 
support functionalization with different affinity tags. Structures are compiled from 
www.lumiprobe.com.  
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Squaraine fluorophores are excellent NIR fluorophores with high extinction 
coefficient (ε).31,32 Squaraines can be synthesized via simple condensation of squaric 
acid with two equivalence of a secondary aniline (Figure 1.9).37,38  However their 
planar structure limits aqueous solubility and renders them susceptible to quenching 
via aggregation.31 Moreover, the oxycyclobutenolate core is electron deficient and 
susceptible to nucleophilic attacks.38,39 Encapsulation of the oxycyclobutenolate 
moiety with tetralactam macrocycles (rotaxane), as reported by Arunkumar et al. 
dramatically increases aqueous stability, but the aqueous solubility remains 
suboptimal.40 Unfortunately, all squaraine dyes suffer from low quantum yields in 
aqueous media. Addition of aqueous-soluble sulfonate groups successfully increases 
solubility but does not improve quantum yields.41  
 
 
Figure 1.9: General synthesis of squaraine fluorophores. Condensation between 
squaric acid and two equivalence of aniline forms squaraine fluorophores. 
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BODIPYs have been heavily investigated for their potential as NIR imaging probes. 
Since their introduction in the mid-1900s, the BODIPY scaffold has been exhaustively 
modified to achieve excitation and emission wavelengths beyond 800 nm, with moderate 
to high quantum yields.32 BODIPYs are highly modular; every aryl position on the 
molecule can be modified (Figure 1.6). Unfortunately, like squaraine and cyanines, their 
extended π-conjugation limits aqueous solubility. Sulfonated visible-light BODIPYs 
show increased aqueous solubility42–44, however, sulfonated NIR BODIPYs are 
unstable.45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18 
 
 
Sulfonated Fluorophores  
 
Sulfonation is frequently used to enhance the aqueous solubility and brightness of 
hydrophobic fluorophores in water.34,46,47 In fact, most commercially available 
fluorophores, both visible and NIR, have at least one sulfonate (Figure 1.10). Sulfonates 
are excellent at solubilizing hydrophobic compounds for two reasons. First, their 
tetrahedral geometry helps prevent stacking of the planar dye. Second, sulfonic acids are 
strong acids, usually with negative pKas. Their high acidity ensures ionization across a 
wide pH range leading to an increase in polarity.46 However, the aqueous solubility 
endowed by sulfonates also prevents cellular membrane diffusion.47–49 As a result, 
sulfonated fluorophores are generally restricted to applications utilizing fixed cells or use 
in vitro assays.  
 
Protection or masking of anionic groups is a common strategy to deliver polar 
charged compounds into live cells.50,51 For example, Calcein AM is a protected 
fluorophore with its negatively charged carboxylates protected (masked) as neutral esters. 
Upon cellular entry, Calcein AM is deprotected (unmasked) by intracellular esterases and 
retained by cells (Figure 1.11). Unfortunately, the design of sulfonate-protecting groups 
is not as straightforward as other polar groups. While esterification of a carboxylic acids 
yields stable esters, sulfonate esters are generally unstable.52 Their alpha-carbon is highly 
electrophilic, which is prone to nucleophilic attacks that could lead to promiscuous 
sulfonate deprotection and non-specific alkylation of biomolecules. For example, ethyl 
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methanesulfonate (EMS) is a common DNA alkylation agent used to induce G:C to A:T 
mutations.  
 
 
Figure 1.10: Commercially available sulfonated fluorophores. Structures of Alexa 
Fluors were drawn without linkers and obtained from 
https://www.atdbio.com/content/34/Alexa-dyes. 
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Figure 1.11: Protection of Calcein AM. Polar carboxylic acids are masked with neutral 
esters, which grants cell permeability. Activity of esterase unmasks the esters to polar 
carboxylic acids, which are retained by cells. 
 
 
 
 
In 2011, Rusha and Miller successfully formulated an esterase-labile stable 
protecting group for sulfonates. Using this group, they delivered a sulfonated 
fluorophore, dansyl sulfonate, into live Chinese Hamster Ovarian (CHO) cells.48 
Unfortunately, this remains the only example of protecting groups designed to deliver 
sulfonated molecules into live cells. 
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Red-shifted Rhodamines 
 
In 2008, Fu et al. revolutionized fluorescent probe design when they replaced the 
oxygen in a xanthene fluorophore called Pyronin Y with silicon (Figure 1.12). This 
single substitution red-shifted both the excitation and emission wavelengths by about 90 
nm, from 552ex/569em to 641ex/659em.53 Since the introduction of Si-Pyronin Y (SiP), a 
wave of novel Si-rhodamines (SiR) have subsequently emerged (Figure 1.13).39,54–57  
 
 
Figure 1.12: O to Si substitution causes large bathochromic shifts in Pyronin Y 
  
 
 
 
Rhodamines are within the xanthene family and like Si-Pyronin Y, Si-rhodamines (SiR) 
exhibit similar bathochromic shifts. For example, the excitation and emission 
wavelengths of tetramethylrhodamine (TMR) (548ex/572em) are red-shifted by ~90 nm in 
Si-tetramethylrhodamine (SiTMR) (643ex/662em) (Figure 1.13).47 Moreover, Si-
rhodamines retain the high photostability of rhodamines with quantum yields comparable 
to near-IR cyanine fluorophores.57,58  These advantageous properties of Si-rhodamines 
have been exploited for live-cell, in vivo, and super-resolution microscopic 
techniques.10,55,59–61 
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Figure 1.13: Structures of rhodamines and substituted rhodamines and their optical 
properties 
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Other group 14 elements such as Tin (Sn) and germanium (Ge) have been installed 
into rhodamines to yield Sn-rhodamine (SnR) and Ge-rhodamine (GeR), respectively 
(Figure 1.13). GeR has slightly smaller bathochromic shifts compared to SiR. The 
excitation and emission wavelengths of SnR were not reported but SnR has been shown 
to have extremely low photostability, even when compared to Cy5.62 Phosphorus and 
sulfones have also been installed into rhodamines to yield P-rhodamines (PR) and SO2-
rhodamines (SO2R), respectively (Figure 1.13). Remarkably, both PR and SO2R 
displayed noteworthy bathochromic shifts of ~140 nm in both excitation and emission, 
although PR suffers from a large drop in quantum yield.63,64 
 
The bathochromic shifts of SiR have been attributed to the narrowing of the HOMO-
LUMO energy gap. Cyclic voltammetry analysis of Si-Pyronin Y (SiP) showed increased 
and decreased HOMO and LUMO energy levels, respectively. Density functional theory 
(DFT) analyses of SiR produced similar results. However, DFT analyses of phosphorus-
rhodamine (PR) and sulfone-rhodamine (SO2R) also showed decreased HOMO energy 
levels. Because of the higher HOMO energy levels and lower LUMO energy levels, the 
HOMO-LUMO energy gap of PR and SO2R are even smaller than those found in SiR. 
The HOMO energy levels are thought to be affected inductively through the σ-bonds of 
the bridging atom and the adjacent carbons, where higher inductivity yields higher 
HOMO levels. On the other hand, the lowered LUMO energy levels are projected to be 
the result of overlapping p orbitals of the aromatic carbon atoms adjacent to the bridging 
atom with s orbitals of the methyl groups (σ*−π* conjugation) and/or d orbitals of the 
bridging atom (d*−π* conjugation).53,62–64 
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Oxazines and Si-Oxazines (Azasilines) 
 
Oxazines are one of the most compact classes of NIR fluorophores. They are 
structurally related to rhodamines, but with a nitrogen substitution in position 9 (Figure 
1.14). Unlike other larger NIR fluorophores such as ICG, sulfonation readily confers 
water-solubility to oxazines.49 The typical excitation and emission wavelengths of 
oxazines are 640 and 660 nm, respectively, which are 90 nm longer than rhodamines. 
 
 
Figure 1.14: Structural similarities between rhodamines and oxazines 
 
 
 
 
Substitution of the oxygen atom (silylation) with the goal of bathochromic shifts in 
both excitation and emission has been exclusively investigated in the rhodamine scaffold. 
Given the structural similarities between oxazines and rhodamines, oxygen to silicon in 
oxazines should also result in similar bathochromic shifts. Both Si-rhodamines and 
oxazines absorb and emit at wavelengths ~90 nm longer than rhodamines. Thus, the 
combination of the two modifications could potentially yield “Si-oxazines” (azasilines) 
with excitation and emission wavelengths over 700 nm (Figure 1.15). 
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Figure 1.15: Potential spectral properties of azasilines. TMR is red-shifted by 90 nm 
via O to Si substitution. SiR and oxazines have similar excitation/emission wavelengths. 
Exchanging O for Si in oxazines (azasilines) could potentially yield an additional red-
shift of 90 nm.     
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Summary 
 
NIR fluorophores are highly desirable for two important reasons. First, there is 
minimal spectral overlap between NIR fluorophores, endogenous chromophores and 
visible-light fluorophores (chemical or protein). Since the light source used to excite NIR 
fluorophores do not excite endogenous chromophores, autofluorescence and 
phototoxicity are minimal. Moreover, NIR fluorophores are compatible with visible-light 
fluorophores in multicolored fluorescence assays. Second, NIR light is poorly absorbed 
by endogenous chromophores, it can penetrate deeper into and out of tissues, with a 
lower loss of the fluorescence signal, allowing for deep tissue in vivo imaging. 
Unfortunately, most NIR fluorophores are large hydrophobic molecules that suffer from 
poor photostability and/ or low aqueous solubility. Large hydrophobic surface areas can 
cause nonspecific binding, which decreases the signal to noise ratio in both in vitro and in 
vivo.65 Sulfonation increases aqueous solubility, but prevents membrane diffusion and 
thus, limits the applications of sulfonated fluorophores to in vitro or fixed-cell assays. 
Moreover, molecular size can override the effects of sulfonates, as in the case of ICG, 
highlighting the difficulty in solubilizing larger organic molecules. Taken together, new 
classes of more compact, photostable NIR fluorophores, especially ones that absorb and 
emit over 700 nm, coupled with strategies to deliver sulfonated fluorophores across the 
cellular membrane are necessary to expand the utility of fluorescent probes. 
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CHAPTER II: 
 
Reductively-Labile Sulfonate Ester Protecting Groups That Are 
Rapidly Cleaved By Physiological Glutathione 
 
 
 
 
 
Adopted from Choi and Miller66 
 
 
 
 
 
 
 
 28 
 
 
Summary 
 
Sulfonates are frequently used to endow aqueous solubility on hydrophobic molecules. 
However, most sulfonated molecules cannot diffuse across the cellular membrane, which limits 
their applications in live cells. Only few sulfonate protecting groups exist and their cleavage 
often requires harsh chemical conditions. Here, I describe the first sulfonate esters that are 
cleaved by mild reductants such as glutathione, and their application to deliver a sulfonated 
dye into live mammalian cells. 
 
 
 
Introduction 
 
Sulfonation can dramatically increase the aqueous solubility of NIR fluorophores. In 
fact, many commercially available fluorophores are sulfonated (Figure 1.10). Although 
sulfonated fluorophores are more soluble, they are generally membrane impermeable.47–49 
A common strategy to deliver polar species into cells is through protection, where the 
polar group is chemically converted (masked) into a neutral one.50,51 For example, the 
carboxylic acids on calcium sensor Calcein are converted to acetoxymethyl (AM) to yield 
the cell permeable Calcein AM (Figure 1.11). However, unlike carboxylates, sulfonates 
cannot be protected via simple esterification because the resulting sulfonate esters are 
generally highly electrophilic.52 Alkylation by EMS highlights the instability of sulfonate 
esters (Figure 2.1).   
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Figure 2.1: EMS alkylation of guanine into O6-ethylguanine.  
 
 
 
 
Protecting groups may either carry a chemical or enzymatic trigger. However, 
enzymes are known to hold a certain degree of specificity towards their substrates. 
Further modifications of the protecting group motif may decrease or abolish enzyme 
recognition and/or activity completely.67 Payload release efficiency is dependent on 
enzyme concentration and thus, could vary between cell types.68  In contrast, chemical 
deprotection does not require enzyme recognition, which confers higher modularity by 
design. Potentially, longer, bulkier targeting moieties could be accommodated without 
losing efficiency.  
 
There are a few examples of sulfonate protecting groups that cleave under chemical 
conditions; unfortunately, none were specifically designed for use in biological 
settings.52,69,70 Reported protecting groups often require harsh chemicals for deprotection, 
such as overnight treatment with sodium hydroxide or refluxing in ammonia.52,69  
 
The only examples of sulfonate protecting groups applicable for in cellulo use were 
reported by Rusha and Miller in 2011.48 While several protecting groups were explored, 
the acetoxy trifluoromethyl benzyl (AcOTFMB) group was most efficient at sulfonate 
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release. AcOTFMB is based on the α-trifluromethyl benzyl (TFMB) scaffold, which is 
comprised of three essential parts. First, a benzene group acts as the core scaffold, 
connecting the release trigger and sulfonate payload. Second, a trifluoromethyl group 
(CF3) is mounted on the alpha carbon to stabilize it against nucleophilic attacks. The 
inductive electron-withdrawing properties of the CF3 group confer stability through the 
destabilization of the partial positive charge or carbocation formed during nucleophilic 
substitution reactions (electronic deactivation). Compared to the methylated alpha 
carbons counterparts, trifluoromethylated alpha carbons were shown to be more resistant 
to nucleophilic attacks.71 Third, an esterase-labile acetoxy trigger is installed at the para 
position. (Figure 2.2).48,52    
 
Later, Pauff and Miller reported the TFMT, which is an acid-labile TFMB-based 
sulfonate protecting group..72 While TFMT cannot release sulfonates under biological 
conditions, it underlines the modularity of TFMB. Hence, I hypothesize that TFMB can 
be modified with biocompatible chemical release triggers. 
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Figure 2.2: Design and proposed release mechanism of the esterase-labile 
AcOTFMB. Esterase activity instigates 1-6 elimination, releasing the sulfonate and 
forming a p-quinone methide as a byproduct.      
 
 
 
 
The interior and exterior of cells are reducing and oxidizing, respectively.73 The 
reducing intracellular environment of mammalian cells is largely maintained by the 
tripeptide glutathione (GSH), which protects the cell against oxidative stress.74–76 
Maintenance of a high GSH level, typically 0.5-10 mM, is essential for cell survival. 
Thus, I proposed to take advantage of the reductive intracellular environment of cells by 
designing reductively-labile protecting groups (RLPG) for sulfonates. These RLPGs 
would be stable under oxidizing, extracellular environment, but rapidly release sulfonates 
after cell entry due to the activity of GSH.  
 
The design of our RLPG is based on AcOTFMB. However, instead of an acetoxy 
group, a disulfide group is placed in the para position of the TFMB scaffold. This 
disulfide serves as a linker between the TFMB and modular group. Reduction of the 
disulfide bond (reductive cleavage) should liberate the sulfonate via a 1,6-elimination 
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mechanism and forms a p-thioquinone methide, an poorly studied compound that is 
rarely if ever isolated (Figure 2.3).77–79 However, like p-quinone methide formed from 
AcOTFMB, the p-thioquinone methide is expected to further react and form adducts with 
nucleophiles.48 
 
      
Figure 2.3: Design and proposed release mechanism of reductively-labile sulfonate 
protecting groups. Reduction of the disulfide bond (labeled as reducible bond) triggers 
1-6 elimination, releasing the sulfonate and forming a thioquinone methide intermediate, 
which further reacts and forms an adduct with GSH. 
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Results and Discussions 
 
Newman-Kwart rearrangement is a common method access thiophenols via the 
oxygen to sulfur rearrangement of the dimethyl thiocarbamate, followed by base-
mediated hydrolysis (Figure 2.4).80,81. However, this rearrangement often requires 
temperatures over 250 °C.82,83 Thus, a synthetic route was adopted to access thiophenols. 
 
 
  
Figure 2.4: Accessing thiophenols using Newman-Kwart rearrangement. O-
thiocarbamates rearranges under high heat to form S-thiocarbamates, which are 
hydrolyzed to yield thiolphenols.  
 
 
 
 
First, the Ruppert-Prakash reaction was used to convert commercially available 4-
thiomethyl-benzaldehyde into the trimethylsilyl (TMS) protected trifluoromethyl alcohol 
2.1. Treatment of aq. HCl and THF mixture removed the TMS group to yield the free 
benzyl alcohol 2.2. NBS treatment converted the thiomethyl group into the N-
(thio)succinimide 2.3. The succinimidyl group was removed with sodium borohydride 
reduction to afford the free thiophenol 2.4, which was subsequently reacted with S- 
methyl methanethiosulfonate to yield the methyl disulfide, MeSSTFMB 2.5. Finally, the 
dansyl sulfonate ester (dansylate) MeSSTFMB-Dan 2.6 was formed using DABCO and 
dansyl chloride (Scheme 2.1). 
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Scheme 2.1: Synthesis of MeSSTFMB-Dan. Reagents and conditions: (a) Me3SiCF3, 
TBAF, THF, 0 °C to RT; (b) NBS, DCM, RT; (c) 1:1 aq. HCl/THF, RT; d) NaBH4, 
MeOH, -40 °C to RT; e) MeSSO2Me, MeOH, pH 8 buffer, RT; (f) dansyl chloride, 
DABCO, DCM, RT. 
 
 
 
 
Dansyl sulfonate contains an aromatic sulfonate. Esterification of the sulfonate 
increases the dipole moment by lowering the electron density of the oxygen atom on the 
sulfonate, which in turn, elongates both excitation and emission wavelengths. For 
example, the free dansyl-sulfonate and AcOTFMB-Dan have excitation/emission 
wavelengths of 332/498 nm and 346/557 nm, respectively (Figure 2.5). Further, 
successful delivery and release of free sulfonates into live cells yields diffusive 
fluorescence, whereas uncleavable sulfonate esters, such as TFMB, which lacks a trigger 
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are membrane permeable, but form aggregate puncta in the cell membrane (Figure 2.6).48 
Therefore, dansylates offer a convenient way to determine and evaluate sulfonate release 
efficiency, both in vitro and in live cells.48 
 
 
   
Figure 2.5: Excitation and emission wavelengths of dansyl-sulfonate and 
AcOTFMB-Dan. Dansyl sulfonate esters have red-shifted fluorescence compared to free 
sulfonate fluorophore. 
 
 
 
 
Our goal was to design a RLPG that can deliver their entire payload (sulfonates) into 
live cells within 15 minutes, which is the typical incubation time for commercial 
fluorescent probes. To evaluate the sulfonate release efficiency, MeSSTFMB-Dan, along 
with other dansylates were incubated in the presence of reducing agents, either GSH (5 
mM) or TCEP (1 mM) (Figure 2.6). TFMB-Dan lacks a release trigger and served as the 
uncleavable, negative control.48 Two simple alkyl dansylates (methyl, 2.7 and ethyl, 2.8) 
were also included to test whether GSH was capable of releasing sulfonates by acting as a 
nucleophile (Figure 2.7). If GSH can initiate efficient sulfonates release from simple 
alkyl dansylates, it would imply that enzyme-free sulfonate delivery could be achieved 
without special sulfonate protecting groups.  
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Figure 2.6: Structures of simple, reductively-labile MeSSTFMP and non-cleavable 
TFMB dansylates. From left to right, methyl dansylate (MeO-Dan), ethyl dansylate 
(EtO-Dan), TFMB, and MeSSTFMB-Dan.  
 
 
 
 
 
 
 
 
 
Figure 2.7: Potential sulfonate release from simple dansylates via nucleophilic 
activity of GSH. Simple dansylates are electrophilic. GSH may act as a nucleophile and 
trigger sulfonate release via a SN2 mechanism.  
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Each sample was incubated with a reducing agent for 15 minutes at room 
temperature in the dark and then analyzed with high performance liquid chromatography 
(HPLC) to detect free dansyl sulfonates, unreacted dansylates, and the byproducts formed 
during reductive cleavage. As expected, TFMB-Dan did not yield free sulfonate under 
any reducing conditions tested (Figure 2.8). Surprisingly, the stability of the simple alkyl 
dansylates was higher than initially thought; the majority of the alkyl dansylates remained 
intact after treatment. Only minuscule amounts of free dansyl sulfonates were released by 
the methyl-dansylate (MeO-Dan) (Figure 2.9 and 2.10). In stark contrast, the 
MeSSTFMB-Dan afforded ~30% and ~90% cleavage from GSH and TCEP treatment, 
respectively (Figure 2.11). 
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Figure 2.8: TFMB-Dan does not release sulfonates under reducing conditions. HPLC 
analysis of TFMB-Dan treated under different reducing condition. TFMB-Dan was 
treated with reducing agents or PBS alone for 15 minutes.  Control samples were injected 
immediately, without prior incubation. Each peak is labeled with its retention time. 
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Figure 2.9: MeO-Dan does not efficiently release sulfonates under reducing 
conditions. HPLC analysis of MeO-Dan treated under different reducing conditions. 
MeO-Dan was treated with reducing agents or PBS alone for 15 minutes.  Control 
samples were injected immediately, without prior incubation. Each peak is labeled with 
its retention time. 
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Figure 2.10: EtO-Dan does not release sulfonates under reduction conditions. HPLC 
analysis of EtO-Dan treated under different reducing conditions. EtO-Dan was treated 
with reducing agents or PBS alone for 15 minutes.  Control samples were injected 
immediately, without prior incubation. Each peak is labeled with its retention time. 
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Figure 2.11: MeSSTFMB-Dan can release sulfonates under reducing conditions. 
HPLC analysis of MeSSTFMP-Dan treated under different reducing conditions. 
MeSSTFMB-Dan was treated with reducing agents or PBS alone for 15 minutes.  Control 
samples were injected immediately, without prior incubation. Each peak is labeled with 
its retention time. 
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While MeSSTFMB-Dan displayed enhanced cleavage rates compared to simple 
alkyl dansylates, sulfonate release under 5 mM GSH treatment was rather slow. The 
sluggish cleavage rate under GSH treatment in vitro suggests that free sulfonate release in 
cells would be too slow. To increase the rate of sulfonate release, I revisited my design of 
the MeSSTFMB and postulated that the oxidation potential of the disulfide bond could be 
increased by replacing benzene with a pyridine ring (Figure 2.12). Compared to benzene, 
pyridine contains an electron withdrawing nitrogen, which lowers the electron density of 
the disulfide bond, making it more electrophilic.  
 
 
 
Figure 2.12: Substitution of benzene with pyridine as the core scaffold of RLPG. The 
disulfide bond becomes more electrophilic due to the electron withdrawing effects of the 
nitrogen. 
 
 
 
 
The synthetic scheme to access the pyridyl-RLPG or MeSSTFMP (2.14) was mostly 
analogous to that of the MeSSTFMB. However, pyridyl-thiophenols could not be 
accessed via demethylation with NBS due to the unavailability of commercial S-methyl 
pyridines. Instead, pyridyl-thiophenols were accessed through thiol surrogates, a strategy 
reported by Itoh and Mase.84,85 In this strategy, aryl halides are coupled to thiols using 
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palladium-catalyzed coupling chemistry. Later, the aryl sulfides are cleaved to yield the 
aryl thiols (Figure 2.13). 
 
 
 
Figure 2.13: Accessing aryl thiophenols using thiol surrogates. A thiol surrogate is 
added on to the aryl ring using palladium-catalyzed coupling and subsequently cleaved 
with base to generate the thiophenol. 
 
 
 
 
In our revised route, palladium-catalyzed coupling was performed between 
commercially available 5-bromo-2-pyridinecarboxaldehyde and 2-ethylhexyl 3-
mercaptopropionate to yield the thiol surrogate 2.9. Ruppert–Prakash reaction and 
subsequent TMS deprotection with aq. 1M HCl and THF mixture afforded the alcohol 
2.11. The ester was removed via base-mediated elimination with sodium methoxide to 
yield the thiophenol 2.12. Subsequent treatment with methyl methanethiosulfonate and 
dansylation afforded MeSSTFMP 2.13 and the final product MeSSTFMP-Dan 2.14, 
respectively (Scheme 2.2). 
 
As I hypothesized, MeSSTFMP-Dan displayed improved cleavage rates compared to 
MeSSTFMB.  Complete cleavage occurred within 15 minutes under all conditions tested 
(Figure 2.14). Aside from dansyl-sulfonate with a retention time of 3.7 minutes, another 
byproduct with a retention time of 9.6 minutes was also detected.  
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Scheme 2.2: Synthesis of MeSSTFMP-Dan. Reagents and conditions: (a) 2-Ethylhexyl 
3-Mercaptopropionate, Pd2(dba)3, Xantphos, toluene, reflux; (b) Me3SiCF3, TBAF, THF, 
0 °C to RT; (c) 1:1 aq. HCl/THF, RT; (d) toluene, 25% NaOMe in MeOH, RT; (e) 
MeSSO2Me, MeOH, pH 8 buffer, RT; (f) dansyl chloride, DABCO, DCM, RT. 
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Figure 2.14: MeSSTFMP-Dan rapidly releases sulfonates under reducing 
conditions. HPLC analysis of MeSSTFMP-Dan treated under different reducing 
conditions. MeSSTFMP-Dan was treated with reducing agents or PBS alone for 15 
minutes.  Control samples were injected immediately, without prior incubation. Each 
peak is labeled with its retention time. The peak at 9.8 minutes is presumed to be derived 
from the thioquinone methide cleavage product. 
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To further characterize the byproducts formed during reduction, MeSSTFMP-Dan 
was incubated with different reducing agents, including GSH (5 mM), BME (1 mM), 
DTT (1 mM) and TCEP (1 mM). Interestingly, liquid chromatography mass spectrometry 
(LCMS) revealed a major byproduct with the mass of 194 under all four conditions, 
suggesting the formation of a two-electron reduction product of the p-thioquinone 
methide intermediate (Figure 2.15).  Minor byproducts unique to each reduction 
condition were detected with masses consistent with adducts formed between the p-
thioquinone methide and reducing agents (Figure 2.16 and 2.17). For example, unique to 
DTT treatment of MeSSTFMP-Dan, a product with a mass of 346 and retention time of 
5.1 minutes was detected.  Interestingly, a byproduct with the mass of 384 was 
consistently detected, suggesting a dimer of the two-electron reduction product. 
 
 
 
Figure 2.15: Generation of p-thioquinone methide during MeSSTFMP-Dan 
reduction. Thioquinone methide becomes further reduced, forming the two-electron 
reduction product (major) and reductant adduct (minor). 
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Figure 2.16: Mass of products detected during MeSSTFMP-Dan reduction. 
LCMS analysis of MeSSTFMP-Dan after treatment with reducing agents. Background 
spectrum of PBS alone (gold); purified dansyl sulfonate (blue); and MeSSTFMP-Dan 
control without pre-incubation (red). Treatment conditions included: PBS alone (green); 
5 mM GSH (purple); 1 mM BME (navy blue); 1 mM DTT (orange); or 1 mM TCEP 
(black). Retention times are labeled with their observed masses (MH+) in red boxes.  
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Figure 2.17: Purposed structures of byproducts detected with LCMS during 
MeSSTFMP-Dan reduction. The mass of each by product is listed beneath the 
structures. 
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To isolate and fully characterize the major byproduct, a larger scale reduction of 
MeSSTFMP-Dan was performed. Only the disulfide form of the two-electron reduction 
product 2.15 was isolated.  HPLC and LCMS analyses of 2.15 pretreated with TCEP 
showed identical retention time, mass, and photodiode array (PDA) signals as the major 
byproduct observed from MeSSTFMP-Dan reduction (Figure 2.18 and 2.19). Taken 
together, unlike quinone methides that typically yield nucleophilic addition products, 
thioquinone methides have a strong preference for a further reduction to form a two-
electron reduction product.48,86  
 
 
 
Figure 2.18: Reduction of disulfide 2.16 yields the byproduct observed during 
MeSSTFMP-Dan reduction. LCMS analysis of disulfide and MeSSTFMP-Dan after 
TCEP treatment. PBS blank run (blue); Disulfide 2.16 alone in PBS (red); Reduction of 
with 1 mM TCEP (green) compared to reduction of MeSSTFMP-Dan (orange). Retention 
times are labeled with their observed masses (MH+) in red boxes.  
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Figure 2.19: Photodiode array spectra are identical between the isolated disulfide 
and the byproduct observed during MeSSTFMP-Dan reduction.  Control was 
immediately injected (a), Compound 2.15 (b), and MeSSTFMP-Dan (c) were pretreated 
with 1 mM TCEP for 15 minutes prior to injection.  
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To directly compare the rate of sulfonate release between MeSSTFMB and 
MeSSTFMP, I monitored their reductive cleavage in real-time, based on the fluorescence 
signal from free dansyl sulfonates. Each dansylate was treated with either 1 mM BME, 1 
mM DTT, 1 mM TCEP, or 5 mM GSH, and monitored for 15 minutes. Consistent with 
the HPLC results, MeSSTFMB-Dan did not show significant sulfonate release when 
treated with BME, DTT, or GSH. Although sulfonate release was substantially faster 
with TCEP, it did not reach completion. Conversely, complete sulfonate liberation from 
MeSSTFMP-Dan occurred within 3 minutes under all conditions (Figure 2.20). 
 
 
Figure 2.20: Real-time fluorescence monitoring of sulfonate release from 
MeSSTFMB-Dan and MeSSTFMP-Dan. Reductive cleavage of (a) MeSSTFMB-Dan 
and (b) MeSSTFMP-Dan under different reducing conditions in PBS. Cleavage was 
followed by monitoring the fluorescence emission of dansyl sulfonate (498 nm).  
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Quinone methides are an electrophilic species and potentially cytotoxic.87 To evaluate the 
toxicity of MeSSTFMB and MeSSTFMP, the LD50 was determined in HeLa cells using a 
standard cell proliferation assay called XTT. HeLa cells were dosed with each dansylate 
at concentrations up to 30 μM, the aqueous solubility limit of MeSSTFMB-Dan. TFMB-
Dan and MeSSTFMB-Dan showed no signs of toxicity at the tested concentrations. In 
contrast to MeSSTFMB-Dan, MeSSTFMP-Dan displayed a higher level of toxicity, 
though only at concentrations above 10 μM. AcOTFMB-Dan displayed higher toxicity 
with an LD50 of ~ 8 μM (Figure 2.21). This could imply that quinone methides are 
inherently more cytotoxic than thioquinone methides. 
 
 
 
 
Figure 2.21: Cytotoxicity of different dansylates. Live HeLa cells were treated with 
different concentrations of each dansylate (30 µM – 0.11 µM) for 1 hour. Toxicity was 
assessed using an XTT cell proliferation assay 48 hours after treatment. Signals were 
normalized to the DMF vehicle control.  
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Lastly, sulfonate delivery was evaluated in live cells. HeLa cells were treated with 1 
μM dansylates for 15 minutes and then imaged with fluorescent microscopy. Diffusive 
blue fluorescence signifies the successful release of dansyl-sulfonate release in the 
cytoplasm, whereas yellow puncta indicate aggregation within the cellular membrane. 
Dansyl-sulfonate could not enter cells, while TFMB-Dan was retained in the cell 
membranes and formed puncta in the cell membrane (Figure 2.22 and 2.23). As 
reported, AcOTFMB-Dan efficiently delivered dansyl-sulfonate into cells (Figure 2.23). 
Both MeSSTFMB-Dan and MeSSTFMP-Dan delivered sulfonates into cells, but 
MeSSTFMP-Dan did so more rapidly (Figure 2.22). However, alkyl dansylates did not 
deliver any appreciable amounts dansyl-sulfonate into cells (Figure 2.23). 
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Figure 2.22: Delivery of dansyl sulfonate into live HeLa cells with RLPGs. 
Fluorescence (a-c) and differential interference contrast (DIC) images (d-f) of cells 
treated with TFMB-Dan (a and d); MeSSTFMB-Dan (b and e); or MeSSTFMP-Dan (c 
and f). Images are shown at 50x magnification. Composite pictures g-i are 
pseudocolored. Scale bars = 10 µm. 
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Figure 2.23: Live images of HeLa cells treated with different dansylates. DIC images 
(a-e), fluorescence images (f-j), and composite images (k-o) of cells treated with DMF 
vehicle (a, f, k); dansyl sulfonate (b, g, l); AcOTFMB-Dan (c, h, m); MeO-Dan (d, i, n); 
or EtO-Dan (e, j, o). Composite images are pseudo-colored to match the fluorescence 
seen through the eyepiece. Scale bar = 10 µm. 
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Conclusion 
 
Sulfonation can greatly enhance aqueous solubility at the cost of membrane 
permeability. In this work, I introduced two reductively labile protecting groups, 
MeSSTFMB and MeSSTFMP that are capable of intracellular delivery of sulfonates 
(Figure 2.23). The synthetic scheme for obtaining both RPLGs are short and 
straightforward, consisting of only 5 steps allowing for easy derivation. 
  
MeSSTFMB-Dan was capable of sulfonate release in vitro, albeit at a slow rate. 
Despite the slow release in vitro, it delivered an appreciable amount of dansyl-sulfonate 
into live HeLa cells. Importantly, MeSSTFMB did not show any toxicity in Hela cells at 
concentrations up to 30 μM. In contrast, MeSSTFMP-Dan rapidly released sulfonates, 
both in vitro and in cells. Cytotoxicity was slightly higher, but only at concentrations 
above 10 μM. Moreover, the cytotoxicity of both RLPGs was lower than the reported 
AcOTFMB. These results suggest that cytotoxicity could be correlated with the rate of 
(thio)quinone methide generation and/ or that thioquinone methides are less toxic than 
quinone methides.87  
 
Finally, the different release rates of MeSSTFMB and MeSSTFMP can be exploited 
for either sustained or rapid sulfonate release, respectively. Given their many attributes, I 
envision MeSSTFMB, MeSSTFMP, and other RLPGs to not only find widespread 
applications as delivery scaffolds for sulfonated molecules, but also encourage the design 
of novel sulfonated probes and drugs. 
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Materials and Methods 
 
General:  
Commercially available products were used without purification and purchased form 
Aldrich, Frontier Scientific, Matrix, Oakwood, Chem-Impex, Combi-Blocks, or TCI. 
Anhydrous solvents were purchased from Acros.  Compounds were purified with the 
CombiFlash Rf+ system or manual silica gel column with HPLC-grade ChromoSolv 
solvents purchased from Sigma-Aldrich.   
 
NMR spectra (1H, 19F, and 13C) were obtained on a Varian Mercury 400 or Bruker 
Ascend 500. Analytical HPLC was performed on an Agilent 1100 equipped with a 
Zorbex C8 column and a PDA detector (G1315A DAD). LCMS was performed on an 
Agilent 1260 Infinity equipped with a Zorbex SB-C18 column and a 6130 Quadrupole 
detector High resolution mass spectrometry was performed at the UMass Mass 
Spectrometry core on a Thermo Scientific Orbitrap Velos Pro.  Excitation and emission 
data were obtained on Fluoromax-4. Images were acquired with a Nikon Eclipse E600, 
equipped with a Hamamatsu Orca-ER and a mercury lamp. Data were graphed and fitted 
using Graphpad Prism 7. NMR spectra were analyzed with MestReNova. Images were 
processed with Fiji (ImageJ) 
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Excitation and Emission Spectra of Dansylates 
 
Compounds at 1 mM stock concentration were diluted 1:500 in PBS pH 7.4 (6 µL 
into 3 mL) to a final concentration of 2 µM. For all acquisitions, the temperature was 
maintained at 20 °C and slit widths were set to 1 mm (excitation) and 5 mm (emission).  
 
Equipment and Conditions: 
System: Horiba Scientific FluoroMax-4 
Temperature Controller: Newport Model 350B 
Acquisition software: FluorEssence 
Temperature: 20 °C 
 
 
 
 
 
 
 
 
 
 
 
 
 59 
 
 
Fluorometric Detection of Dansylate Cleavage  
 
Compounds at 1 mM stock concentration were diluted 1:500 in PBS pH 7.4 (6 µL 
into 3 mL) to a final concentration of 2 µM. The release of dansyl sulfonate was 
monitored using wavelengths of 324 nm (excitation) and 498 nm (emission). The 
temperature was maintained at 20°C and slit widths were set to 1 mm (excitation) and 5 
mm (emission). Data points were collected every 10 seconds for 15 minutes. To establish 
fluorescence baseline, reducing agents were added 50 seconds after the initial time point.  
 
Equipment and Conditions: 
System: Horiba Scientific FluoroMax-4 
Temperature Controller: Newport Model 350B 
Acquisition software: FluorEssence 
Temperature: 20°C 
 
Concentrations and volumes of reducing agents: 
Reducing Agent Stock Concentration 
in PBS (mM) 
Volume Added 
(µL) 
Final Concentration 
(mM) 
TCEP 500 6 1 
DTT 500 6 1 
BME 500 6 1 
Glutathione 500 30 5 
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HPLC Analysis of Dansyl Cleavage 
 
Compounds at 10 mM stock concentration in DMF were diluted 1:1000 in PBS pH 
7.4 (1 µL in 1 mL) with or without reducing agent to a final concentration of 10 µM. 
Compound standards were injected into the HPLC immediately after filtration through a 
0.45 µM PTFE syringe filter. In all other conditions, compounds were incubated in the 
dark at room temperature for 15 minutes prior to filtration and injection. The HPLC 
column was equilibrated for at least 25 minutes at 1.4 mL/min prior to sample injection. 
TCEP was used at 1 mM and GSH was used at 5 mM. 
 
Equipment and Conditions: 
Injection volume: 200 µL 
HPLC system: Agilent Series 1100 
Filter: 13mm 0.45 µM PTFE 
Column: Agilent Zorbax XDB-C8 µm 4.6 mm x 150 mm 
Wavelength monitored: 290 nm / 800 nm (reference) 
System: 0.1% TFA H2O/acetonitrile 
 
Ramp:    
Time (m) % Acetonitrile Flow rate (mL/ min) 
2 0 1.4 
15 90 1.4 
17 90 1.4 
18 0 1.4 
Post-run (25 minutes) 0 1.4 
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LCMS Analysis of Dansyl Cleavage 
 
Sample preparation and concentrations were identical to the HPLC protocol. The 
LCMS column was equilibrated for 5 minutes at 1.0 mL/min before each injection. 
TCEP, DTT and BME were used at 1 mM and GSH was used at 5 mM.  
 
Note: The injection protocol of the LCMS auto-sampler took approximately 2 minutes to 
complete; total incubation time was therefore about 17 minutes for test samples and 2 
minutes for control samples. 
 
Equipment and Conditions: 
Injection volume: 100 µL 
LCMS system: Agilent 1260 Infinity with auto-sampler, 6130 Quadrupole LC/MS 
Column: PoroShell 120 EC-C18 4.6x150 mm 2.7 µm 
Wavelength monitored: 290 nm / 595 nm (reference) 
System: 0.1% aq. formic acid/acetonitrile 
 
Ramp:    
Time (m) % Acetonitrile Flow rate (mL/ min) 
0 0 1.0 
8 100 1.0 
10 100 1.0 
Post-run (5 minutes) 0 1.0 
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Live Cell Imaging 
 
 
Cell culture 
HeLa cells were cultured with DMEM containing 10% FBS and 1% Pen/Strep at 37 
°C. Cells were first cultured in T-75 TC flasks to 70% confluency, then trypsinized and 
diluted to 50,000 cells/mL. Coverslips (#1.5 18 mm) were seeded in a 10 cm petri dish 
using 10 mL of cell solution. Cells were allowed to adhere for 20 hours at 37°C. 
 
Staining 
Coverslips were washed twice with HBSS and placed in a 35 mm petri plate 
containing HBSS (2 mL). Dansylates (2 µl of a 1 mM stock) were added to achieve a 
final concentration of 1 µM and then incubated for 15 minutes at 37°C. After incubation, 
the coverslips were washed twice with HBSS and mounted using a technique adapted 
from Chazotte.88 Instead of using VALAP, Vaseline was used to seal the chamber and 
200 µL of HBSS was used to fill the chamber to prevent the formation air bubbles. 
 
Image processing 
Raw 16-bit images were cropped to the desired 2 square inch frames (600 dpi) and 
normalized to the pixel intensity (min: 350, max: 3500), except for TFMB-Dan (min: 
350, max: 6000). Those images were then converted to 8-bit images, and a scale bar was 
applied (7.85 pixel/µm). Composite pictures were prepared using the merge channel 
function in the FIJI software, and pseudocolored to match the fluorescence seen through 
the eyepiece (longpass emission filter). 
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Equipment 
Coverslips: Deckgläser No. 1.5, 18 mm round glass 
Microscope slides: Fisherfinest Premium Plain 
Microscope: Nikon Eclipse E600 
Camera: Hamamatsu Orca-ER with controller 
Objective: Nikon Plan 50x oil immersion 
Filter Set: Nikon UV-2A (330-380 nm bandpass excitation; 420 nm longpass emission) 
Light Source: Chiu Technical Corporation 100W Mercury Lamp 
Exposure time: 100 ms 
Imaging processing software: FIJI 
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Toxicity Assay 
 
 
Cell culture 
HeLa cells were cultured with DMEM containing 10% FBS and 1% Pen/Strep at 37 
°C. Cells were first cultured in T-75 TC flasks to 70% confluency, then trypsinized and 
diluted to 50,000 cells/mL. 96-well plates were seeded with 5000 cells/well. Cells were 
allowed to adhere for 24 hours at 37 °C.  
 
XTT Assay 
DMEM medium was removed via aspiration and the cells were washed once with 
HBSS (100 μL). After washing, the wells were filled with HBSS (50 μL). Compounds 
(50 μL) were added and incubated for 1 hr at 37 °C. After treatment, the compounds were 
removed via aspiration and the cells were washed once with HBSS (100 μL). The cells 
were supplied with fresh DMEM (100 μL) and allowed to proliferate for 48 hours at 37 
°C. Activated XTT reagent (50 μL) were added and incubated at 37°C for 4 hour. Wells 
were read at 490 mm and 660 mm. 
 
Compounds at 10 mM stock concentration in DMF were first diluted in HBSS (6 µL 
in 1 mL), then serially diluted (1:2) in HBSS. Concentrations ranged from 60 μM to 1.9 
μM at 2X. 
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Equipment 
Plates: BD 35-3072 
Plate Reader: BioRad IMark 
XTT Reagent: ATCC XTT Kit 30-1011K 
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Synthetic Mehods 
 
 
 
Trimethyl(2,2,2-trifluoro-1-(4-(methylthio)phenyl)ethoxy)silane (2.1) 
 
 
In a 50 mL round bottom flask, 4-(Methylthio)benzaldehyde (2 g, 13.2 mmol)  and 
trimethyl(trifluoromethyl)silane (3 mL, 20.3 mmol) were dissolved in anhydrous THF 
(13.5 mL) under argon. The temperature was lowered to 0°C, followed by the dropwise 
addition of 1 M TBAF in THF (70 µL, 0.07 mmol). The reaction was raised to room 
temperature and stirred for 10 minutes. The solvent was removed under reduced pressure 
and the product was purified by silica gel chromatography (0-7.5% EtOAc/hex) to afford 
a pale yellow oil (2.1 g, 7.14 mmol, 94%).  1H NMR (400 MHz, CDCl3) δ 7.39 (d, J = 
8.4 Hz, 2H), 7.26 (m, 2H), 4.91 (q, J = 6.4 Hz, 1H), 2.49 (s, 3H), 0.14 (s, 9H). 19F NMR 
(376 MHz, CDCl3) δ -78.53 (d, J = 6.4 Hz). 13C NMR (101 MHz, CDCl3) δ 139.8, 132.1 
– 132.0 (m), 128.1 – 127.9 (m), 125.9, 124.2 (q, J = 283.6 Hz), 72.9 (q, J = 32.3 Hz), 
15.3, -0.3. HR-EIMS m/z calculated for C12H18F3OSSi+: 295.0794, found: 295.0779 
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1-((4-(2,2,2-trifluoro-1-((trimethylsilyl)oxy)ethyl)phenyl)thio)pyrrolidine-2,5-dione 
(2.2) 
 
 
In a 50 mL round bottom flask, compound 2.1 (860 mg, 2.9 mmol) and NBS (781 
mg, 4.4 mmol) were dissolved in anhydrous DCM (6 mL) under argon. The reaction was 
stirred in the dark at room temperature for 24 hours. The solvent was removed under 
reduced pressure and the product was purified by silica gel chromatography (neat DCM) 
to afford a white solid (1.1 g, 2.9 mmol, 97%). 1H NMR (400 MHz, CDCl3) δ 7.58 – 7.54 
(m, 2H), 7.41 (d, J = 8.0 Hz, 2H), 4.88 (q, J = 6.4 Hz, 1H), 2.84 (s, 4H), 0.09 (s, 9H). 19F 
NMR (376 MHz, CDCl3) δ -78.31 (d, J = 6.4 Hz). 13C NMR (101 MHz, CDCl3) δ 176.4, 
137.0, 134.9, 131.3, 128.5 – 128.4 (m), 123.9 (q, J = 283.6 Hz), 72.6 (q, J = 32.4 Hz), 
28.6, -0.3. HR-EIMS m/z calculated for C15H19F3NO3SSi+: 378.0802, found: 
378.0808. 
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1-((4-(2,2,2-trifluoro-1-hydroxyethyl)phenyl)thio)pyrrolidine-2,5-dione (2.3) 
 
 
In a 50 mL round bottom flask, compound 2.2 (250 mg, 0.9 mmol) was dissolved in 
1:1 1 M aq. HCl/THF (10 mL) and stirred at room temperature for 1.5 hours. THF was 
first removed under reduced pressure, then the product was extracted with EtOAc (3 x 25 
mL). The organic layers were combined and washed with H2O (3 x 50 mL) and brine (50 
mL), then dried over Na2SO4. The solvent was removed under reduced pressure and the 
product was purified by silica gel chromatography (0-70% EtOAc/hex) to afford a white 
solid (200 mg, 0.65 mmol, 87%). 1H NMR (400 MHz, CD3OD) δ 7.47 (s, 4H), 5.04 (q, J 
= 7.2 Hz, 1H), 2.83 (s, 4H). 19F NMR (376 MHz, CD3OD) δ -79.61 (d, J = 7.1 Hz, 1H). 
13C NMR (101 MHz, CD3OD) δ 177.7, 136.3 – 136.2 (m), 135.7, 128.5, 128.4 – 128.2 
(m), 124.7 (q, J = 282.8 Hz), 71.0 (q, J = 31.5 Hz), 28.3. HR-EIMS m/z calculated for 
C12H11F3NO3S+: 306.0406, found: 306.0412. 
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2,2,2-trifluoro-1-(4-mercaptophenyl)ethan-1-ol (2.4) 
 
 
In a 200 mL round bottom flask, compound 2.3 (300 mg, 0.98 mmol) was dissolved 
in anhydrous methanol (20 mL) and degassed three times at -40°C. NaBH4 (400 mg, 11 
mmol) was added to the reaction in small proportions. The reaction was raised to room 
temperature and stirred under argon for 3 hours. The reaction was quenched using glacial 
acetic acid (20 mL). Toluene (50 mL) was added to the reaction mixture and the solvents 
were removed under reduced pressure. The crude product was dissolved in EtOAc (50 
mL), washed with H2O (3 x 50 mL) and brine (50 mL), then dried over Na2SO4. The 
solvent was removed under reduced pressure and the product was purified by silica gel 
chromatography (0–30% EtOAc/hex) afforded a white solid (100 mg, 0.48 mmol, 49%). 
1H NMR (400 MHz, CDCl3) δ 7.37 – 7.28 (m, 4H), 4.98 (dq, J = 6.4, 4.4 Hz, 1H), 3.51 
(s, 1H), 2.48 (d, J = 4.4 Hz, 1H). 19F NMR (376 MHz, CDCl3) δ -78.55 (d, J = 6.4 Hz). 
13C NMR (101 MHz, CDCl3) δ 133.1, 131.1 – 131.1 (m), 129.1, 128.2 – 128.1 (m), 124.1 
(q, J = 283.1 Hz)*, 72.4 (q, J = 32.2 Hz). [*Only 3 of the 4 peaks for the quartet at 124.06 
are visible.]  HR-EIMS m/z calculated for C8H6F3OS-: 207.0097, found: 207.0091. 
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2,2,2-trifluoro-1-(4-(methyldisulfanyl)phenyl)ethan-1-ol (2.5) 
 
In a 25 mL round bottom flask, compound 2.4 (58 mg, 0.24 mmol) and S-methyl 
methanethiosulfonate (42 mg, 0.33 mmol) were dissolved in anhydrous MeOH (3 mL) 
under argon. Degassed 100 mM sodium phosphate pH 8 buffer (4 mL) was added to the 
reaction. The reaction was stirred at room temperature under argon for 2.5 hours. The 
reaction mixture was poured into EtOAc (50 mL), washed with H2O (3 x 25 mL) and 
brine (25 mL), then dried over Na2SO4. The solvent was removed under reduced pressure 
and the product was purified by silica gel chromatography (0-30% EtOAc/hex) afforded a 
white solid (70 mg, 0.28 mmol, 98%).  1H NMR (400 MHz, CDCl3) δ 7.58 – 7.54 (m, 
2H), 7.44 (d, J = 8.4 Hz, 2H), 5.04 – 4.97 (m, 1H), 2.78 – 2.73 (m, 1H), 2.45 (s, 3H). 19F 
NMR (376 MHz, CDCl3) δ -78.38 (d, J = 6.8 Hz). 13C NMR (101 MHz, CDCl3) δ 138.8, 
132.3 – 132.2 (m), 128.2 – 128.0 (m), 127.0, 124.1 (q, J = 283.2 Hz), 72.4 (q, J = 32.2 
Hz), 22.9. 
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2,2,2-trifluoro-1-(4-(methyldisulfanyl)phenyl)ethyl 5-(dimethylamino)naphthalene-
1-sulfonate (2.6) 
 
 
In a 50 mL round bottom flask, compound 2.5 (18 mg, 0.07 mmol), DABCO (11 mg 
0.1 mmol), and dansyl chloride (24 mg, 0.09 mmol) were dissolved in anhydrous DCM 
(3 mL) under argon. The reaction was stirred at room temperature under argon for 3 
hours. The solvent was removed under reduced pressure and the product was purified by 
silica gel chromatography (0-30% EtOAc/hex) to afford a yellow solid (20 mg, 0.04 
mmol, 59%). 1H NMR (400 MHz, CDCl3) δ 8.46 (dt, J = 8.8, 1.2 Hz, 1H), 8.22 – 8.17 
(m, 1H), 8.08 (dd, J = 7.2, 1.2 Hz, 1H), 7.56 (dd, J = 8.4, 7.6 Hz, 1H), 7.36 (dd, J = 8.4, 
7.2 Hz, 1H), 7.18 – 7.09 (m, 3H), 7.03 (d, 8.4 Hz), 5.59 (q, J = 6.4 Hz, 1H), 2.83 (s, 6H), 
2.37 (s, 3H). 19F NMR (376 MHz, CDCl3) δ -75.86 (d, J = 6.4 Hz). 13C NMR (101 MHz, 
CDCl3) δ 151.7, 139.7, 132.0, 131.4, 130.3, 129.7, 129.5, 128.9, 128.6, 126.9, 125.7, 
122.6, 122.1 (q, J = 282.3 Hz), 119.2, 115.5, 78.2 (q, J = 34.7 Hz), 45.40, 22.76. HR-
EIMS m/z calculated for C21H21F3NO3S3+: 488.0630, found: 488.0666. 
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Methyl 5-(dimethylamino)naphthalene-1-sulfonate (2.7)  
 
In a 50 mL round bottom flask, dansyl chloride (100 mg, 0.37 mmol) and DABCO 
(50 mg, 0.45 mmol) were dissolved in methanol (10 mL). The reaction was stirred for 6 
hours at room temperature. The solvent was removed under reduced pressure and the 
crude mixture was dissolved in EtOAc (50 mL). The organic layer was washed with H2O 
(3 x 50 mL) and brine (50 mL), then dried over Na2SO4. Removal of solvent under 
reduced pressure yielded a pure yellow oil (30 mg, 0.11 mmol, 30%). 1H NMR (400 
MHz, CDCl3) δ 8.61 (dt, J = 8.8, 1.2 Hz, 1H), 8.28 (dd, J = 7.2, 1.2 Hz, 1H) 8.26 – 8.23 
(m, 2H), 7.63 – 7.52 (m, 2H), 7.21 (dd, J = 7.6, 0.7 Hz, 1H), 3.72 (s, 3H), 2.89 (s, 6H). 
13C NMR (101 MHz, CDCl3) δ 151.8, 131.6, 130.8, 130.4, 129.9, 129.8, 128.8, 123.0, 
119.3, 115.6, 56.4, 45.4. HR-EIMS m/z calculated for C13H16NO3S+: 266.0845, found: 
266.0869 
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Methyl 5-(dimethylamino)naphthalene-1-sulfonate (2.8)  
 
In a 50 mL round bottom flask, dansyl chloride (100 mg, 0.37 mmol) and DABCO 
(41 mg, 0.37 mmol) were dissolved in ethanol (5 mL). The reaction was stirred at room 
temperature for 4 hours. The solvent was removed under reduced pressure and the 
product was purified by silica gel chromatography (0-20% EtOAc/hex) to afford a yellow 
oil (100 mg, 0.29 mmol, 80%). 1H NMR (400 MHz, CDCl3) δ 8.59 (dt, J = 8.8, 1.2 Hz, 
1H), 8.27 (dd, J = 7.6, 1.2 Hz, 2H), 7.56 (ddd, J = 18.4, 8.4, 7.6 Hz, 2H), 7.20 (dd, J = 
7.6, 0.4 Hz, 1H), 4.07 (q, J = 6.8 Hz, 2H), 2.88 (s, 6H), 1.25 (t, J = 7.2 Hz, 3H). 13C 
NMR (101 MHz, CDCl3) δ 151.7, 131.5, 131.4, 130.4, 129.9, 129.8, 128.6, 123.0, 119.4, 
115.5, 67.1, 45.4, 14.7. HR-EIMS m/z calculated for C14H18NO3S+: 280.1002, found: 
280.1027 
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2-ethylhexyl 3-((6-formylpyridin-3-yl)thio)propanoate (2.9) 
 
To a 200 mL round bottom flask equipped with a reflux condenser was added 5-
Bromo-2-pyridinecarboxaldehyde (1 g, 5.4 mmol), 2-Ethylhexyl 3-Mercaptopropionate 
(1.3 g, 5.9 mmol), tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct 
(Pd2(dba)3·CHCl3) (123 mg, 0.12 mmol) and Xantphos (156 mg, 0.27 mmol). The flask 
was first flushed with argon, then anhydrous toluene (30 mL) and DIPEA (1.4 g, 8 mmol) 
were added in series. The reaction was refluxed at 130°C under argon for 4.5 hours. The 
reaction was cooled to room temperature and filtered with Celite. The solvent was 
removed under reduced pressure and the product was purified by silica gel 
chromatography (0-30% EtOAc/hex) to afford a golden yellow oil (1.4 g, 4.33 mmol, 
80%). 1H NMR (400 MHz, CDCl3) δ 9.93 (d, J = 0.8 Hz, 1H), 8.56 (dd, J = 2.4, 0.8 Hz, 
1H), 7.80 (dd, J = 8.0, 0.4 Hz, 1H), 7.66 (ddd, J = 8.4, 2.4, 0.8 Hz, 1H), 4.01 – 3.90 (m, 
2H), 3.26 (t, J = 7.2 Hz, 2H), 2.66 (t, J = 7.2 Hz, 2H), 1.54 – 1.44 (m, 1H), 1.31 – 1.16 
(m, 8H), 0.81 (t, J = 7.5 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 192.4, 171.1, 149.8, 
148.1, 140.2, 134.6, 121.5, 67.4, 38.6, 33.7, 30.3, 28.8, 27.1, 23.7, 22.9, 14.0, 10.9. HR-
EIMS m/z calculated for C17H26NO3S+: 324.1628, found: 324.1655. 
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2-ethylhexyl 3-((6-(2,2,2-trifluoro-1-((trimethylsilyl)oxy)ethyl)pyridin-3-
yl)thio)propanoate (2.10) 
 
In a 200 mL round bottom flask, compound 2.9 (2.11 g, 6.5 mmol) and 
trifluoromethyltrimethylsilane (1.08 g, 7.6 mmol) were dissolved in anhydrous THF (50 
mL) under argon. The temperature was lowered to 0°C, followed by the dropwise 
addition of 1 M TBAF in THF (100 µL, 0.1 mmol). The reaction was then raised to room 
temperature and stirred for 3 hours. The solvent was removed under reduced pressure and 
the product was purified by silica gel chromatography (0-20% EtOAc/hex) to afford a 
clear oil (2 g, 5.08 mmol, 78%).  1H NMR (400 MHz, CDCl3) δ 8.50 (dd, J = 2.4, 0.8 Hz, 
1H), 7.71 (dd, J = 8.0, 2.4 Hz, 1H), 7.54 (d, J = 8.4 Hz, 1H), 5.04 (q, J = 6.4 Hz, 1H), 
4.04 – 3.95 (m, 2H), 3.19 (t, J = 7.2 Hz, 2H), 2.64 (t, J = 7.6 Hz, 2H), 1.59 – 1.50 (m, 
1H), 1.37 – 1.20 (m, 8H), 0.86 (t, J = 7.6 Hz, 6H), 0.11 (s, 9H). 19F NMR (376 MHz, 
CDCl3) δ -77.69 (d, J = 6.4 Hz). 13C NMR (101 MHz, CDCl3) δ 171.4, 153.5 – 153.4 
(m), 149.1, 137.7, 133.4, 123.8 (q, J = 284.0 Hz), 122.4 – 122.2 (m), 74.3 (q, J = 31.7 
Hz), 67.3, 38.7, 34.2, 30.3, 28.9, 28.7, 23.7, 22.9, 14.0, 10.9, -0.4. HR-EIMS m/z 
calculated for C21H35F3NO3SSi+: 466.2054, found: 466.2094. 
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2-ethylhexyl 3-((6-(2,2,2-trifluoro-1-hydroxyethyl)pyridin-3-yl)thio)propanoate 
(2.11) 
 
 
In a 200 mL round bottom flask, compound 2.10 (800 mg, 1.7 mmol) was dissolved 
in 1:1 aq.1M HCl/THF (100 mL) and stirred at room temperature overnight. THF was 
first removed under reduced pressure, then the product was extracted with EtOAc (3 x 50 
mL). The organic extracts were combined, washed with H2O (3 x 50 mL) and brine (50 
mL), then dried over Na2SO4. The solvent was removed under reduced pressure and the 
product was purified by silica gel chromatography (0-30% EtOAc/hex) to afford a pale 
yellow oil (600 mg, 1.53 mmol, 89%). 1H NMR (400 MHz, CDCl3) δ 8.54 (d, J = 1.6 Hz, 
1H), 7.74 (dd, J = 8.4, 2.4 Hz, 1H), 7.35 (d, J = 8 Hz, 1H), 5.00 (q, J = 6.4 Hz, 1H), 4.08 
– 3.91 (m, 2H), 3.21 (t, J = 7.2 Hz, 2H), 2.64 (t, J = 7.2 Hz, 2H), 1.60 – 1.50 (m, 1H), 
1.37 – 1.21 (m, 8H), 0.86 (t, J = 7.2 Hz, 6H). 19F NMR (376 MHz, CDCl3) δ -78.05 (d, J 
= 6.39 Hz). 13C NMR (101 MHz, CDCl3) δ 171.9, 149.4 - 148.8 (m), 148.6, 138.0, 134.3, 
123.9 (q, J = 283.9 Hz), 122.62 - 122.53 (m), 70.63 (q, J = 31.9 Hz), 67.39, 38.6, 34.1, 
30.3, 28.9, 28.8, 23.7, 22.9, 14.0, 10.9. HR-EIMS m/z calculated for C18H27F3NO3S+: 
394.1658, found: 394.1694. 
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2,2,2-trifluoro-1-(5-mercaptopyridin-2-yl)ethan-1-ol (2.12) 
 
In a 200 mL round bottom flask, compound 2.11 (432 mg, 1.1 mmol) was dissolved 
in anhydrous toluene (20 mL) and degassed 25% sodium methoxide in methanol (10 mL) 
under argon. The reaction was stirred at room temperature for 3 hours. The reaction was 
quenched with glacial acetic acid (10 mL). The solvents were removed under reduced 
pressure and the crude material was dissolved EtOAc (50 mL). The organic layer was 
washed with H2O (3 x 50 mL) and brine (50 mL), then dried over Na2SO4. The solvent 
was removed under reduced pressure and the product was purified by silica gel 
chromatography (0-50% EtOAc/hex) afforded an off-white solid (120 mg, 0.57 mmol, 
52%). 1H NMR (400 MHz, CDCl3) δ 8.56 – 8.46 (m, 1H), 7.69 (dd, J = 8.2, 2.4 Hz, 1H), 
7.30 (d, J = 8.0 Hz, 1H), 5.16 (d, J = 7.2 Hz, 1H), 5.02 – 4.95 (m, 1H), 3.52 (s, 1H). 19F 
NMR (376 MHz, CDCl3) δ -78.20 (d, J = 6.8 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 
148.3 – 148.2 (m), 147.8, 137.6, 130.1, 123.9 (q, J = 284.0 Hz), 122.5 (m), 70.6 (q, J = 
32.0 Hz). HR-EIMS m/z calculated for C7H7F3NOS+: 210.0195, found: 210.0215. 
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2,2,2-trifluoro-1-(5-(methyldisulfanyl)pyridin-2-yl)ethan-1-ol (2.13) 
 
In a 50 mL round bottom flask, compound 2.12 (120 mg, 0.57 mmol) and S-methyl 
methanethiosulfonate (72 mg, 0.57 mmol) were dissolved in anhydrous MeOH (4 mL) 
under argon. Degassed 100 mM sodium phosphate pH 8 buffer (3 mL) was then added. 
The reaction was stirred at room temperature under argon for 3 hours. The reaction 
mixture was poured into EtOAc (50 mL), washed with H2O (3 x 25 mL) and brine (25 
mL), then dried over Na2SO4. The solvent was removed under reduced pressure and the 
product was purified by silica gel chromatography (0-20% EtOAc/hex) to afford an off-
white solid (100 mg, 0.39 mmol 69%). 1H NMR (400 MHz, CDCl3) δ 8.71 –  8.68 (m, 
1H), 7.96 (dd, J = 8.4, 2.4 Hz, 1H), 7.40 (d, J = 8 Hz, 1H), 5.30 – 5.20 (m, 1H), 5.07 – 
4.98 (m, 1H), 2.48 (s, 3H). 19F NMR (376 MHz, CDCl3) δ -78.04 (d, J = 7.52 Hz). 13C 
NMR (101 MHz, CDCl3) δ 149.5 (m), 146.9, 136.3, 135.8, 123.9 (q, J = 284.0 Hz), 122.7 
(m), 70.6 (q, J = 32.1 Hz), 22.9. HR-EIMS m/z calculated for C8H9F3NOS2+: 256.0072, 
found: 256.0095. 
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2,2,2-trifluoro-1-(5-(methyldisulfanyl)pyridin-2-yl)ethyl 5 
(dimethylamino)naphthalene-1-sulfonate (2.14) 
 
 
In a 50 mL round bottom flask, compound 2.13 (100 mg, 0.39 mmol), DABCO (44 
mg, 0.39 mmol) and dansyl chloride (127 mg, 0.47 mmol) were dissolved in anhydrous 
DCM (6 mL) under argon. The reaction was stirred at room temperature under argon for 
3 hours. The solvent was removed under reduced pressure and the product was purified 
by silica gel chromatography (0-25% EtOAc/hex) to afford a yellow solid (62 mg, 0.21 
mmol, 32%).  1H NMR (400 MHz, CDCl3) δ 8.51 (d, J = 8.4 Hz, 1H), 8.36 (d, J = 1.6 
Hz, 1H), 8.22 (d, J = 8.4 Hz, 1H), 8.18 (dd, J = 7.2, 0.8 Hz, 1H), 7.61 – 7.54 (m, 1H), 
7.50 (dd, J = 8.4, 2.4 Hz, 1H), 7.44 (dd, J = 8.0, 7.2 Hz, 1H), 7.22 (d, J = 8.4 Hz, 1H), 
7.17 (d, J = 7.6 Hz, 2H), 5.71 (q, J = 6 Hz, 1H), 2.85 (s, 6H), 2.41 (s, 3H). 19F NMR (376 
MHz, CDCl3) δ -75.34 (d, J = 6.4 Hz). 13C NMR (125 MHz, CDCl3) δ 151.8, 147.5, 
146.8, 135.9, 134.5, 132.2, 131.0, 130.8, 129.7, 129.5, 128.9, 122.9, 122.7, 121.9 (q, J = 
280.1 Hz), 119.2, 115.5, 78.7 (q, J = 33.9 Hz), 45.4, 22.9. HR-EIMS m/z calculated for 
C20H20F3N2O3S3+: 489.0583, found: 489.0625. 
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1,2-bis(6-(2,2,2-trifluoroethyl)pyridin-3-yl)disulfane (2.15) 
  
In a 50 mL round bottom flask, 2.14 (50 mg, 0.1 mmol) was dissolved in ACN (9 
mL). TCEP hydrochloride (286 mg, 1 mmol) was dissolved separately in H2O (10 mL) 
and adjusted to pH 7. The two solutions were combined and stirred at room temperature 
for 2 hours. The reaction mixture was poured into brine (50 mL) and the product was 
extracted with diethyl ether (3 x 20 mL). The combined organic layers were washed with 
brine (50 mL) and dried over Na2SO4. The solvent was removed under reduced pressure 
and the product was purified by silica gel chromatography (0-20% EtOAc/hex) to afford 
an off-white solid (6 mg, 0.016 mmol, 16%). 1H NMR (400 MHz, CDCl3) δ 8.66 (dd, J = 
2.4, 0.6 Hz, 2H), 7.83 (dd, J = 8.2, 2.5 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 3.60 (q, J = 10.6 
Hz, 3H). 19F NMR (376 MHz, CDCl3) δ -64.68 (t, J = 10.6 Hz). 13C NMR (125 MHz, 
CDCl3) δ 150.1 - 190.3 (m), 149.2, 137.0, 133.1, 125.2 (q, J = 275.6 Hz), 124.8, 42.3 (q, 
J = 29.5 Hz). HR-EIMS m/z calculated for C14H11F6N2S2+: 285.0262, found: 
285.0251. 
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CHAPTER III:  
Silicon Substitution in Oxazine Dyes Yields Near-Infrared Azasiline 
Fluorophores That Absorb and Emit Beyond 700 Nm 
 
 
 
 
Adopted from Choi and Miller89 
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Summary 
 
Near-Infrared (NIR) fluorophores are generally large hydrophobic molecules owing to 
their extended π-conjugation. Large hydrophobic surfaces decreases aqueous solubility 
and promote nonspecific binding to proteins. The repertoire of commercial available NIR 
fluorophore is also largely limited to cyanines, which has low photostability. Thus, 
smaller and more photostable NIR dyes are desired. Oxygen to silicon substitution 
(silylation) can dramatically red-shift the excitation and emission wavelengths of 
rhodamine fluorophores from the orange to the far-red, without significantly increasing 
the overall size through π-conjugation extension. Here, I describe the design, synthetic 
approaches, and properties of azasiline fluorophores that resulted from silylation of 
oxazine dyes. 
 
 
Introduction 
 Tissues are most transparent to near-infrared (NIR) light between 650 and 900 nm. 
Consequently, fluorescent images acquired using NIR imaging probes generally have a 
higher signal to noise compared to visible-light probes. Moreover, NIR light is poorly 
absorbed by endogenous chromophores, which minimizes phototoxicity.27 While the 
benefits of NIR fluorophores have long been recognized, the selection of NIR 
fluorophores remains limited, especially ones with high aqueous solubility and 
stability.31,32  
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Most NIR fluorophores are massive hydrophobic molecules. In fact, the quantum 
yields of some NIR fluorophores were not reported in water. Presumably, these dyes have 
low aqueous quantum yield due to aggregation.32 Sulfonation can hugely enhance 
aqueous solubility; but, amongst the popular NIR fluorophore scaffolds discussed in 
CHAPTER I, only sulfonated BODIPYs and cyanines have been reported.34,44 
 
Sulfonated NIR BODIPYs are unstable in water.43,44 Most sulfonated cyanines have 
improved aqueous solubility and higher quantum yields.34 This fact, along with their 
straightforward synthesis, has made cyanine derivatives the most commercially available 
NIR fluorophore. Although popular, cyanines have poor photostability, and larger 
cyanines, such as ICG are still largely insoluble in water. Despite carrying two sulfonates, 
the maximum solubility of ICG in PBS and water are 1 and 5 mg/ml, respectively.90–92 
Taken together, the shortcomings of current NIR fluorophores highlight the urgency to 
develop novel compact NIR fluorophores with high photostability.  
 
The excitation and emission wavelengths of a fluorophore can be red-shifted through 
the expansion of the π-conjugation.34,93 For example, the excitation and emission 
wavelengths of cyanines are red-shifted by approximately 100 nm for each additional 
methine group (double bond) (Figure 3.1). However, expansion of the π-conjugation 
increases hydrophobicity and in turn, leads to aggregation.    
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Figure 3.1: Expansion of π-conjugation red-shifts the fluorescence of cyanines. Each 
additional methine groups red-shifts both excitation and emission by approximately 100 
nm. The name and optical properties are listed below each compound. 
 
 
 
 
A more recent method for red-shifting fluorescence is oxygen to silicon substitution 
(silylation). The first reported silylated xanthene fluorophore is Pyronin Y, which yielded 
a noteworthy 90 nm bathochromic shift in both excitation and emission wavelengths 
(Figure 1.11).  Shortly after the introduction of silylated Pyronin Y (SiP), a tsunami of 
silylated-rhodamines (SiR) and other substituted rhodamines emerged (Figure 1.12). 
Currently, the most red-shifted SiR is the SiR720 (720ex/740em), which absorbs and emits 
~170 nm longer than tetramethylrhodamine (TMR) (Figure 3.2).47,57  
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Figure 3.2: Excitation and emission wavelengths of SiR720 are red-shifted by ~170 
nm compared to TMR 
 
 
 
 
Oxygen to silicon substitution has been exclusively investigated in rhodamines. 
Oxazines are a class of NIR fluorophores that are structurally similar to rhodamines. The 
typical excitation and emission wavelengths of oxazines are between 640 and 670 nm. 
Like rhodamines, oxazines are compact and highly photostable, which are the two key 
attributes for an excellent imaging probe. Further, water-soluble, sulfonated oxazines 
have been reported.49,94 On the basis of structural similarities between rhodamines and 
oxazines, I hypothesized that silylation of oxazines would yield highly photostable 
azasiline fluorophores that absorb and emit over 700 nm. (Figure 1.14).   
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Results and Discussion 
 
The synthesis of oxazines are well documented.49,94–96 One method to access 
oxazines is by reacting aryl ethers with a nitrogen donor, such as 4-
nitrobenzenediazonium tetrafluoroborate. Subsequent acid-mediated cyclization readily 
yields the oxazine fluorophore.94 I first attempted to access azasilines with a synthetic 
route analogous to the one use for oxazines (Scheme 3.1).  
 
Oxazine synthesis: 
 
Attempted azasiline synthesis: 
 
 
 
Scheme 3.1: Modeling azasiline synthesis after oxazines. Reported synthesis for 
oxazines (top) and analogous synthesis scheme for azasilines (bottom). Reaction 
conditions: (a) N2PhNO2. BF4, aq. 2M HCl, MeOH, 0 °C; (b) aq. 2M HCl, EtOH, 80 °C.  
NR = No Reaction. 
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To access the azasiline, commercially available 3-Bromo-N,N-dimethylaniline was 
first treated with n-BuLi and then dichlorodimethylsilane (SiMe2Cl2) to form the aryl 
silane 3.1. A diazo-nitrobenzene moiety was installed to yield 3.2. Unfortunately, acid-
mediated cyclization of 3.2 did not proceed to form the cyclized azasiline. The starting 
material remained unreacted even after overnight treatment with perchloric acid at 80 °C. 
Failure to cyclize 3.2 could be due to the increased bond length introduced by silicon 
and/or the lower nucleophilicity of silanes.  
 
Although azasilines have not been utilized as NIR imaging probes, unsubstituted 
azasilines were previously reported as light emitters in OLED panels.97,98 Interestingly, 
the reported synthetic steps to access azasilines were in the reverse order as our initial 
scheme. Cyclization of those azasilines was achieved via silylation instead of the carbon-
nitrogen bond formation (Figure 3.3).  
 
Our initial scheme: 
 
Reported scheme: 
 
 
Figure 3.3: Possible approaches for accessing azasilines. Azasilines could be accessed 
starting from silanes and cyclized by forming the carbon-nitrogen bond (a) or starting 
from diphenylamine and cyclized via silylation (b).    
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In our revised scheme, diphenylamine was first tetrabrominated using Br2 in acetic 
acid to yield 3.3. Then nitrogen was protected with para-methoxybenzyl chloride (PMB-
Cl) to yield 3.4. Treatment with n-BuLi and SiMe2Cl2 afforded the cyclized PMB-
protected azasiline 3.5. Using palladium-catalyzed coupling chemistry, two azetidine 
groups, which were shown to increase quantum yield, were installed to yield 3.6.47 TFA 
treatment of 3.6 generated a more hydrophobic compound as observed on TLC, which 
was consistent with PMB deprotection. However, the product quickly decomposed from 
a bright yellow to a greenish-brown compound after solvent removal. One-pot PMB 
removal and oxidation of 3.6 with I2 produced a compound with an absorption maxima of 
730 nm. However, the putative product 3.7 isolated with HPLC again degraded after 
solvent removal possibly to yield a polymeric product that was insoluble in acetone, ethyl 
acetate, chloroform, DMSO, and water. 
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Scheme 3.2: Attempted synthesis of an azetidenyl-azasiline. Reaction conditions: (a) 
NBS, acetone, 0 °C, (b) NaH, PMB-Cl, DMF, RT. (c) n-BuLi, SiMe2Cl2, Et2O -78 °C to 
RT. (d) azetidine, Pd2(dba)3, BINAP, NaOtBu, toluene, 110 °C. (e) I2, MeOH, RT. 
 
 
 
 
Despite the instability of the azasiline, the long absorption wavelength of the putative 
product reinforced our commitment to developing NIR azasiline fluorophores. Next, I 
tested whether the azasiline could be stabilized by altering the sterics and/ or electronics 
of the molecule. I designed two azasiline derivatives. The first contained inductively 
deactivating, but π-donating fluorine groups (3.13) and the second contained bulkier 
inductively donating methyl groups (3.18).  
 
 
 133 
 
 
To access the difluoro-azasiline (3.13), palladium-catalyzed coupling was performed 
between commercially available 2-fluoroaniline and 1-bromo-2-fluorobenzene to yield 
the difluoro-diphenylamine 3.8. Tetrabromination was achieved with Br2 and acetic acid 
to yield 3.9. The nitrogen was protected with PMB to yield 3.10. Treatment with n-BuLi 
and SiMe2Cl2 afforded the cyclized dye precursor 3.11. Using palladium-catalyzed 
coupling, two azetidines were installed to yield the leuco-dye 3.12. One-pot PMB 
deprotection and oxidation with I2 gave the final product 3.13 (ASiFluor710). 
Fortuitously, 3.13 readily oxidized and precipitated out of solution during I2 treatment. 
Simple filtering and washing of the precipitant with hexanes and methanol afforded pure 
product (Scheme 3.2). 
 
Encouraged by the successful synthesis of the ASiFluor710, I next determined its 
photophysical characteristics. In ethanol, the excitation and emission wavelengths of the 
ASiFluor710 were 712 and 719 nm, respectively, which is approximately 60 nm longer 
than those of Oxazine 1 (Figure 3.4). The quantum yield and extinction coefficient were 
determined as 0.11 and 60,000 M-1 cm-1, respectively (Figure 3.5). Lamentably, 
ASiFluor710 slowly degraded in PBS. HPLC and LCMS analyses of ASiFluor710 
incubated in 50/50 ACN/PBS mixture for 48 hours revealed a degradation product with a 
peak absorption wavelength of 660 nm and a mass of 306, compared to the parent of 370 
(Figure 3.6 – 3.7).  The degradation product was subsequently isolated and characterized 
(Figure 3.6c). Consistent with the LCMS data, NMR and HRMS analyses revealed the 
structure of a methylated oxazine 3.13′ without any fluorine groups. 
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Scheme 3.3: Synthesis of a difluoro-azasiline (ASiFluor710). Reaction conditions: (a) 
Pd2(dba)3, Xantphos, NaOtBu, toluene, 110 °C. (b) AcOH, Br2, 110 °C. (c) NaH, PMB-
Cl, 15-Crown-5, THF, reflux. (d) n-BuLi, SiMe2Cl2, Et2O -78 °C to RT. (e) azetidine, 
Pd2(dba)3, BINAP, NaOtBu, toluene, 110 °C. (f) I2, MeOH, RT, (g) ACN/PBS, 48 hr, 
RT. 
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    Absorption       Emission 
 
 
 
 
 
Fluorophore λ abs (nm) λem (nm) 
Oxazine 1 646 662 
Cy5.5 684 710 
ASiFluor710 712 719 
ASiFluor730 732 745 
HITC 743 773 
 
Figure 3.4: Excitation and emission of azasilines in ethanol. Absorbance (top left) and 
emission (top right) scans of various fluorophores. Peak absorbance and emission 
wavelengths are listed in the table. 
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a) HITC (EtOH)                        b) ASiFluor730 (EtOH )       c) ASiFluor730 (water)         d) ASiFluor730 (PBS)                e) ASiFluor730 (Tween-20)              
           
f) ASiFluor730 (Dioxane)         g) ASiFluor730 (EG)            h) Cy5.5 (EtOH)                   i) ASiFluor710 (EtOH)          
         
 
j) ASiFluor730 (EtOH)             k) ASiFluor730 (water)        1) ASiFluor730 (PBS)          m) ASiFluor730 (Tween-20)       n) ASiFluor730 (Dioxane)           
                                                          
              
  o) ASiFluor730 (EG)                p ) ASiFluor710 (EtOH)  
       
            
 
Compound Solvent Slope r2 ϕ ε (M−1 cm−1) r2 Brightness 
ASiFluor730 
EtOH 133,500,434 0.9991 0.11 120,601 0.9998 13,817 
water 11,515,019 0.9337 0.01 69,980 0.9949 631 
PBS 15,807,667 0.9750 0.01 52,943 0.9941 549 
0.05% Tween-20 71,799,640 0.9802 0.06 95,030 0.9949 5,592 
ethylene glycol 132,590,701 0.9759 0.13 108,600 0.9999 13,661 
1,4-dioxane 120,154,108 0.9980 0.13 46,270 0.9990 5,942 
ASiFluor710 EtOH 338,139,559 0.9788 0.11 59,570 0.9989 6,285 
 
HITC EtOH 349,572,566 0.9784 0.30    
Cy5.5 EtOH 641,024,853 0.9964 0.20    
 
 
Figure 3.5: Measurement of quantum yields and molar extinction coefficients of 
ASiFluors. Quantum yields (a-i) and molar extinction coefficients (l-p) of ASiFluors. 
Quantum yields were calculated using equation: 
 
𝜙𝑥 = 𝜙𝑆𝑇 [
(𝑠𝑙𝑜𝑝𝑒)𝑥
(𝑠𝑙𝑜𝑝𝑒)𝑆𝑇
] [
𝑛𝑥
2
𝑛𝑆𝑇
2 ] 
   
where slope refers to the slope of absorbance vs. integrated emission and n was the 
refractive index of solvents if different solvents were used between the standard and 
sample x. HITC was used for ASiFluor730 and Cy5.5 was used for ASiFluor710 as 
references. Results are given in the table below the graphs. 
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a) No treatment 
 
 
b) 48 hours in PBS    
 
 
c) Isolated degradation product (3.13′)  
 
 
Figure 3.6: HPLC analysis of AsiFluor710 degradation. Before (a) and after (b) 48hr 
incubation in 50/50 ACN/PBS, and isolated degradation product (c). Each peak’s 
corresponding photodiode array (PDA) spectrum is displayed on the right of each trace. 
HPLC detection wavelength was set 650 nm. 
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a) No treatment 
 
 
b) 48 hours in PBS    
 
 
Figure 3.7: LCMS analysis of AsiFluor710 degradation. LCMS spectra of ASiFluor710 
before (a) and after (b) 48 hour incubation in 50/50 ACN/PBS. Detected mass is reported 
below the retention time. LCMS detection wavelength was set to 280 nm.   
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Although the incorporation of fluorine groups promoted oxidation and allowed for 
the synthesis of azasilines, their electron-withdrawing effects likely increased aqueous 
liability. I predict that degradation was possibly initiated by the hydrolysis of fluorine, 
followed by fluorine-mediated reactions with silicon to form a silylated oxazine 
derivative, which underwent methyl transfer to form the final degradation product 3.13′ 
(Figure 3.8). In contrast, methyl groups are electron donating, which should increase 
aqueous stability.  
 
The dimethyl-azasiline (3.18) was considerably more difficult to synthesize. Our 
initial synthetic route was analogous Scheme 3.3. However, this route failed at the PMB 
protection step, presumably due to the steric hindrance from the two methyl groups. I 
revisited my original synthetic scheme and postulated that cyclization can be achieved via 
palladium-catalyzed coupling (Scheme 3.4). 
 
To access the dimethyl-azasiline, palladium-catalyzed coupling was first performed 
between commercially available azetidine and 3,5-dibromotoluene to yield the 
monobrominated azetindyl-toluene 3.14. Treatment with n-BuLi and SiMe2Cl2 afforded 
the aryl silane 3.15. Dibromation was achieved with NBS treatment to yield 3.16. Ring 
closure was achieved with a palladium-catalyzed coupling between 3.16 and 4-
methoxybenzylamine to yield the cyclized leuco-dye 3.17. Finally, one-pot PMB 
deprotection and oxidation with I2 treatment and subsequent HPLC purification afforded 
the final product 3.18 (ASiFluor730). 
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Figure 3.8: Proposed degradation mechanism of ASiFluor710. 
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Scheme 3.4: Synthesis of a dimethyl-azasiline (ASiFluor730). Reaction conditions: (a) 
azetidine, Pd2(dba)3, BINAP, NaOtBu, toluene, 110 °C. (b) n-BuLi, SiMe2Cl2, Et2O/THF, 
-78 °C to RT. (c) NBS, DCM, 0 °C. (d) 4-Methoxybenzylamine, Pd2(dba)3, BINAP, 
NaOtBu, toluene, 110 °C. (e) I2, MeOH, 0 °C. 
 
 
 
 
ASiFluor730 displayed large bathochromic shifts of approximately 80 nm compared 
to Oxazine 1 (Figure 3.4, 3.5 and 3.9). Incubation in 50/50 ACN/PBS mixture for 48 
hours did not degrade the compound (Figure 3.10). In ethanol, ASiFluor730 had a 
quantum yield and extinction coefficient of 0.11 and 120,000 M-1cm-1, respectively, 
which are comparable to those of Oxazine 1 (0.14 and 118,000 M-1cm-1).29 In ethylene 
glycol and 1,4-dioxane, ASiFluor730 had a quantum yield of 0.13. However, the 
quantum yield of ASiFluor730 dropped to approximately 0.01 in deionized water and 
PBS, which is 11-fold lower than in ethanol. The addition of 0.05% Tween-20 restored 
the quantum yield to 0.06, implying that aggregation may be responsible for the reduced 
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quantum yield in aqueous solvents (Figure 3.5). Like cyanines, incorporation of polar 
groups such as sulfonates could enhance solubility and in turn, increase quantum yields.93 
 
Absorption         Emission 
 
 
 
Solvent λabs (nm) λem (nm) 
Ethanol 732 745 
Water 725 739 
PBS 725 739 
0.05% Tween 20 730 745 
Ethylene Glycol 736 747 
1,4-Dioxane 701 734 
 
 
Figure 3.9: Excitation and emission of ASiFluor730 in various solvents. Absorbance 
(top left) and emission (top right) scans of ASiFluor730. Peak absorbance and emission 
wavelengths are listed in the table. 
 
 
 
 
 
 
 
 
 
 
 143 
 
 
a) 
 
 
b) 
 
 
Figure 3.10: ASiFluor730 is stable in PBS. HPLC analysis of ASiFluor730 incubated in 
ACN/PBS. Before (a) and after (b) incubation after 48 hours. Each peak’s corresponding 
Photodiode array (PDA) spectrum is displayed on the right of each trace. HPLC detection 
wavelength was set 650 nm. 
 
 
 
 
Next, I compared the photostability of the ASiFluors to Oxazine 1 and Cy5.5, a 
cyanine derivative that absorbs and emit at similar wavelengths as the ASiFluors (Figure 
3.11). Each fluorophore was irradiated for one hour at their peak absorption wavelength. 
Oxazine 1 and ASiFluor730 were photostable. ASiFluor710 displayed similar 
photostability in ethanol, but wasn’t tested in PBS due to its aqueous lability. While 
Cy5.5 was photostable in ethanol, it lost ~60% of its fluorescence in PBS.  
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Although not as bright as NIR cyanines, azasilines are currently among the most 
compact NIR fluorophores (Table 3.1). Using molecular weight to excitation wavelength 
ratio (mw: λex) as an estimate for compactness, azasilines are approximately twice as 
compact as ICG. Further, the ASiFluor730 was 1.4X more compact than SiR720, which 
is the most red-shifted SiR.  
 
 
 
Figure 3.11: Azasilines retain the high photostability of oxazines. Each fluorophore 
was irradiated continuously for one hour at their max absorbance wavelength (Oxazine 1 
= 646 nm; Cy5.5 = 684 nm; ASiFluor710 = 710 nm; ASiFluor730 = 730 nm) in ethanol 
(left panel) and PBS (right panel). ASiFluor710 was not tested in PBS due to its 
instability in aqueous solution.  
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Fluorophore Ex 
(nm) 
Em 
(nm) 
MW Length 
(Å) 
Ex : 
Length 
Ex :  
MW 
Distance 
Between 
Ref. 
ASiFluor710 710 720 370 13.08 54.28 1.92 C(22)-C(25) this work 
AsiFluor730 730 740 362 13.08 55.81 2.02 C(24)-C(21) this work 
SiR700 691 712 423 11.93 57.92 1.63 C(8)-C(19) 99 
SiR720 721 740 532 14.52 49.66 1.36 C(37)-C(33) 99 
ICG 775 831 752 17.20 45.06 1.03 C(2)-C(30) 39 
Cy5.5 679 696 483 14.89 45.60 1.41 C(2)-C(25) 39 
Oxazine 1 646 662 324 14.39 44.89 1.99 C(19)-C(24) 29 
HITC (Cy7) 743 772 409 18.03 41.21 1.82 C(2)-C(26) 29 
TTAB  733 757 521 11.51 63.68 1.41 C(29)-C(22) 100 
Sq2 729 739 521 14.27 51.09 1.40 C(35)-C(37) 101 
 
Table 3.1: Size comparison of fluorophores. The length was calculated as the distance 
between the two outer most atoms using Chem3D. The excitation wavelength to 
molecular weight and excitation wavelength to length ratios estimate the compactness of 
the molecule. ICG = Indocyanine Green. TTAB and Sq2 are examples of NIR aza-
BODIPY and squaraine fluorophores, respectively. 
 
 
 
 
Lastly, I characterized ASiFluor730’s behavior in HeLa cells. The cytotoxicity of 
ASiFluor730 was compared to that of Oxazine 1 using a standard cell proliferation assay 
called XTT. Oxazine 1 displayed low toxicity, cell density was decreased by only 25% at 
100 µM treatment. On the other hand, ASiFluor730 displayed moderate toxicity with a 
LD50 of approximately 9.6 µM (Figure 3.12).  
 
Cationic dyes can accumulate in the mitochondria due the charge attraction between 
the negative membrane potential of the mitochondria and the positive charge of cationic 
dyes.102 Certain cationic dyes such as Rhodamine 123 have also been shown to cause 
mitochondrial depolarization that ultimately leads to apoptosis or autophagy via the 
inhibition of key enzymes in the electron transport chain.103–105 I speculate that 
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ASiFluor730 also confer cytotoxicity in a similar manner. Thus, the addition of polar 
anionic groups such as sulfonates could both increase aqueous solubility and lower the 
toxicity of ASiFluors.  
 
Live HeLa cells were stained with ASiFluor730 (5 µM) and then imaged with 
fluorescent microscopy. Azasilines are cationic and thus, may migrate to the 
mitochondria due to the charge attraction between the negative potential of the 
mitochondria and the positive charge on the fluorophore.106–108 To test whether 
ASiFluor730 localizes to the mitochondria, cells were co-stained with MitoTracker 
Green.  
 
 
 
Figure 3.12: Cytotoxicity of ASiFluor730 in HeLa cell. Live HeLa cells were treated 
with different concentrations of ASiFluor730 (100 µM – 0.01 µM) for 1 hour. Toxicity 
was assessed using XTT cell proliferation assay 48 hours after treatment. Signals were 
normalized to the DMF vehicle control. Data was fitted with GraphPad Prism. 
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When used alone, ASiFluor730 gave a robust fluorescent signal, but does not access 
the nucleus (Figure 3.13). MitoTracker Green and ASiFluor730 showed identical 
staining patterns in co-stained HeLa cells, confirming that ASiFluor indeed migrates to 
the mitochondria (Figure 3.13). 
 
 
a) ASiFluor730            b) DIC        c) Composite 
 
 
Figure 3.13: HeLa cells stained with ASiFluor730. Live HeLa cells were incubated 
with ASiFluor730 (5 µM) for 15 minutes and imaged under a fluorescence microscope. 
Fluorescence image of ASiFluor730 (a), DIC (b) and composite (c).  
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a) FITC (MitoTracker Green)     b) ASiFluor730                  c) Composite 
 
 
 
d) DIC          e) composite 
 
 
 
Figure 3.13: ASiFluor730 and MitoTracker Green co-localized in the mitochondria. 
Live Hela cells were first treated with MitoTracker Green (100 nM) for 15 minutes, 
followed by ASiFluor730 (5 µM) for an additional 15 minutes. Fluorescence image of 
MitoTracker Green (a) and ASiFluor730 (b), composite fluorescence image (c), DIC (d), 
and composite of DIC and fluorescence image (e).  
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Conclusions 
 
Silicon to oxygen substitution can dramatically red shift both excitation and emission 
wavelengths without substantially increasing molecular size. However, this phenomenon 
has only been investigated in rhodamines. Using this method of oxygen to silicon 
substitution I introduced two novel azasiline NIR fluorophores based on the oxazine 
scaffold. 
 
Both azasilines displayed large bathochromic shifts, similar to those seen in SiR. The 
emission wavelengths of ASiFluor710 (712ex/719em) and ASiFluor730 (732ex/745em) are 
57 and 83 nm longer than those of Oxazine 1 (646ex/662em), respectively. Although 
ASiFluor710 was unstable and degraded into a methylated oxazine in PBS, it had a 
respectable quantum yield of 0.11 in ethanol. 
 
ASiFluor730 did not degrade in PBS and inherited the high photostability of 
oxazines. In ethanol, ASiFluor730 exhibited similar photophysical properties as Oxazine 
1. The quantum yield was in water was low, but was largely restored with the addition of 
0.05% Tween 20. Although ASiFluor730 has a low quantum yield in water and showed 
moderate toxicity in Hela cells (LD50 = 9.6 µM), it still robustly stained cells.  
 
The azasiline scaffold is one of the most compact NIR fluorophore scaffolds. 
Moreover, the azasiline scaffold contains multiple sites amendable for anchoring linkers, 
affinity tags, and installing water-soluble, polar groups (CHAPTER IV). Combined with 
the NIR fluorescence wavelengths and stability, I envision azasilines will find broad 
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applications in any fluorescence-based assays, including deep tissue imaging, and inspire 
the design of other silylated luminescent probes. 
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Materials and Methods 
 
General:  
 
Commercially available products were used without purification and purchased form 
Combi-Block, Chem-Impex, Sigma-Aldrich, Acros or Oakwood Chemicals. Palladium 
catalysts and ligands were purchased from Combi-Blocks and Chem-Impex. Cy5.5 free 
carboxylic acid was purchased from Lumiprobe. Anhydrous solvents were purchased 
from Acros.  Compounds were purified with the CombiFlash Rf+ system and HPLC-
grade ChromoSolv solvents were purchased from Sigma-Aldrich.  
 
All NMR spectra (1H, 19F, and 13C) were obtained on a Bruker Ascend 500. 
Analytical HPLC was performed on an Agilent 1100 equipped with a Zorbex C8 column 
and a PDA detector (G1315A DAD). Preparatory HPLC was performed on a Varian 
ProStar equipped with Aglient 10-Prep C18 21.2 x 250 mm Column. LCMS was 
performed on an Agilent 1260 Infinity equipped with a Zorbex SB-C18 column and a 
6130 Quadrupole detector. High resolution mass-spec data were obtained on an Agilent 
6520 Q-TOF. Absorption and emission data were obtained on Cary-50 and Fluoromax-4 
instruments, respectively. Data were graphed and fitted using Graphpad Prism 7. NMR 
spectra were analyzed with MestReNova. Images were acquired with an Nikon Eclipse 
E600 and analyzed with ImageJ. 
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Excitation and Emission Spectra of Fluorophores 
 
 
For excitation (absorption), compounds were diluted until the spectrums were 
smooth. For emission, compounds were diluted until the peak signal is below 1x106 CPS. 
The temperature was maintained at 20°C and slit widths varied between compounds. All 
samples were blanked with their respectively blanks prior to analysis.  
 
Equipment and Conditions: 
System: Horiba Scientific FluoroMax-4 
Temperature Controller: Newport Model 350B 
Acquisition software: FluorEssence 
Temperature: 20 °C 
System: Horiba Scientific Cary 50 
Acquisition software: Cary Win UV 
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Live Cell Imaging 
 
 
Cell culture 
HeLa cells were cultured with DMEM containing 10% FBS and 1% Pen/Strep at 37 
°C. Cells were first cultured in T-75 TC flasks to 70% confluency, then trypsinized and 
diluted to 50,000 cells/mL. Coverslips (#1.5 18 mm) were seeded in a 10 cm petri dish 
using 10 mL of cell solution. Cells were allowed to adhere for 20 hours at 37 °C. 
 
Staining 
Coverslips were washed HBSS (3 X) and placed in a 35 mm petri plate containing 5 
µM of ASiFluor730 in HBSS (2 mL) and then incubated for 15 minutes at 37 °C. After 
incubation, the coverslips were washed with HBSS (3 X) and mounted using a technique 
adapted from Chazotte.88 Instead of using VALAP, Vaseline was used to seal the 
chamber and 200 µL of HBSS was used to fill the chamber to prevent the formation air 
bubbles. 
 
Co-staining 
Coverslips were washed HBSS (3 X) and placed in a 35 mm petri plate containing 
HBSS (2 mL). MitoTracker Green (1 µl of a 200 µM stock) was added to achieve a final 
concentration of 100 nM and then incubated for 15 minutes at 37 °C. After incubation, 
the coverslips were washed with HBSS (3 X), placed in HBSS containing 5 µM of 
ASiFluor730 and incubated for an additional 15 minutes at 37 °C. After the second 
incubation, the coverslips were washed with HBSS (3 X) and mounted using a technique 
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adapted from Chazotte.88 Instead of using VALAP, Vaseline was used to seal the 
chamber and 200 µL of HBSS was used to fill the chamber to prevent the formation air 
bubbles. 
 
Image processing 
Raw 16-bit images were cropped to the desired 2 square inch frames (600 dpi) and a 
scale bar was applied (7.85 pixel/µm). Composite pictures were prepared using the merge 
channel function in the FIJI software, and pseudocolored. 
 
Equipment 
Coverslips: Deckgläser No. 1.5, 18 mm round glass 
Microscope slides: Fisherfinest Premium Plain 
Microscope: Nikon Eclipse E600 
Camera: Hamamatsu Orca-ER with controller 
Objective: Nikon Plan 50x oil immersion 
Filter Set: Nikon UV-2A (330-380 nm bandpass excitation; 420 nm longpass emission) 
Filter set: Custom filter cube (Ex: 665/40, FF685 Di02. Em: 747/33) 
Light Source: Chiu Technical Corporation 100W Mercury Lamp 
Exposure time: 100 ms 
Imaging processing software: FIJI 
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HPLC Analysis of ASiFluor Degradation (analytical) 
 
 
Compounds (1 µL of a 10 µM stock) were diluted in 50/50 ACN/PBS (1 mL) and 
incubated in the dark at room temperature for 48 hours. 50 µL was injected into the 
HPLC after filtration through a 0.45 µM PTFE syringe filter. Control samples were 
diluted in ACN, filtered and injected immediately. The HPLC column was equilibrated 
for at least 25 minutes at 1.4 mL/min prior to sample injection.  
 
Equipment and Conditions: 
Injection volume: 200 µL 
HPLC system: Agilent Series 1100 
Filter: 13mm 0.45 µM PTFE 
Column: Agilent Zorbax XDB-C8 µm 4.6 mm x 150 mm 
Wavelength monitored: 650 nm / 800 nm (reference) 
System: 0.1% TFA H2O/acetonitrile 
 
Ramp:    
Time (m) % Acetonitrile Flow rate (mL/ min) 
2 0 1.4 
12 100 1.4 
15 100 1.4 
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HPLC (preparatory) 
 
 
Samples (5 mL) dissolved in 50/50 ACN/H2O were injected into the HPLC after 
filtration through a 0.45 µM PTFE syringe filter. The HPLC column was equilibrated for 
at least 10 minutes at 20 mL/min prior to sample injection.  
 
Equipment and Conditions: 
Injection volume: 5 mL 
HPLC system: Varian ProStar  
Filter: 13mm 0.45 µM PTFE 
Column: Agilent 10-Prep C18 21.2 x 250 mm 
Wavelength monitored: 650 nm  
System: 0.1% TFA H2O/acetonitrile 
 
Ramp:    
Time (m) % Acetonitrile Flow rate (mL/ min) 
5 0 20 
40 65 (3.13′) or 85 (3.18) 20 
42 100 20 
47 100 20 
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LCMS Analysis of ASiFluor Degradation   
 
 
Compounds (1 µL of a 10 µM stock) were diluted in 50/50 ACN/PBS (1 mL) and 
incubated in the dark at room temperature for 48 hours. 10 µL was injected into the 
LCMS after filtration through a 0.45 µM PTFE syringe filter. Control samples were 
diluted in ACN, filtered and injected immediately. The LCMS column was equilibrated 
for at 5 minutes at 0.5 mL/min prior to sample injection.  
 
Equipment and Conditions: 
Injection volume: 10 µL 
LCMS system: Agilent 1260 Infinity with auto-sampler, 6130 Quadrupole LC/MS 
Column: Zorbex SB-C18 2.1x50 mm 1.8 µm 
Wavelength monitored: 280 nm / 595 nm (reference) 
System: 0.1% aq. formic acid/acetonitrile 
 
 
Ramp:    
Time (m) % Acetonitrile Flow rate (mL/ min) 
2 0 0.5 
12 100 0.5 
14 100 0.5 
Post-run (5 minutes) 0 0.5 
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Photostability of ASiFluors 
 
 
Each fluorophore was diluted from a 10 mM DMSO stock to 3.3 µM in ethanol or 10 
µM in PBS. The excitation wavelength was set to match each fluorophore’s absorption 
maxima with a 20 nm slit width. The emission detection wavelength was set to 40 nm 
away from the absorption maxima at the indicated slit width. The fluorescence signal was 
collected every 0.1 seconds for 3700 seconds and normalized to the initial signal. The 
average µAs are listed as an estimate of the relative irradiation intensity at each 
wavelength. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound [µM] Solvent Excitation Slit Emission Slit 
Avg. 
µA 
Oxazine 1 
10 PBS 
646 
20 
 
686 
1 
116 
3.3 EtOH 1 
ASiFluor730 
(18) 
10 PBS 
730 770 
10 95 
  3.3 EtOH 2 
Cy5.5 
10 PBS 
684 724 
2 
141 
3.3 EtOH 1 
ASiFluor710 
(13) 
3.3 EtOH 710 750 2 105 
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Quantum Yield and Extinction Coefficient Determination  
 
 
Compounds were first diluted from a 10 mM DMSO stock into the desired solvent 
(e.g. PBS, water, EtOH, 1,4-Dioxane, 0.05% Tween-20 or ethylene glycol). The first 
dilution solution was allowed to equilibrate in the dark at room temperature for 15 
minutes before a second dilution was made. The second dilution was allowed to 
equilibrate in the dark at room temperature for another 15 minutes before the absorption 
or fluorescence signal was read. Absorbance readings were kept below 0.1 for quantum 
yield samples. Slit widths were set to 2 nm (ex) and 5 nm (em) with 0.1s integration time 
for fluorescence measurements. 
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Toxicity Assay 
 
 
Cell culture 
HeLa cells were cultured with DMEM containing 10% FBS and 1% Pen/Strep at 37 
°C. Cells were first cultured in T-75 TC flasks to 70% confluency, then trypsinized and 
diluted to 50,000 cells/mL. Clear 96-well plates were seeded with 5000 cells/well. Cells 
were allowed to adhere for 24 hours at 37 °C.  
 
XTT Assay 
DMEM medium was removed via aspiration and the cells were washed once with 
HBSS (100 μL). After washing, the wells were filled with HBSS (50 μL). Compounds 
(50 μL) were added and incubated for 1 hr at 37 °C. After treatment, the compounds were 
removed via aspiration and the cells were washed once with HBSS (100 μL). The cells 
were supplied with fresh DMEM (100 μL) and allowed to proliferate for 48 hours at 37 
°C. Activated XTT reagent (50 μL) were added and incubated at 37 °C for 4 hour. Wells 
were read at 490 mm and 660 mm. 
 
Compounds at 10 mM stock concentration in DMSO were first diluted in HBSS (10 
µL in 1 mL), then serially diluted (1:2) in HBSS. Concentrations ranged from 100 μM to 
1 μM at 2X. 
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Equipment 
Plates: BD 35-3072 
Plate Reader: BioRad IMark 
XTT Reagent: ATCC XTT Kit 30-1011K 
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Synthetic Methods 
 
 
 
 
3,3'-(Dimethylsilanediyl)bis(N,N-dimethylaniline) (3.1)  
 
In a 50 mL oven dried round bottom flask, 3-bromo-N,N-dimethylaniline (200 mg, 1 
mmol) was dissolved in anhydrous diethyl ether (10 mL) and anhydrous THF (0.5 mL) at 
room temperature and then cooled to 0 °C. n-BuLi (0.49 ml of 2.5 M, 1.2 mmol) was 
added drop-wise to the reaction. After 1 hour, dichlorodimethylsilane (77 mg, 0.6 mmol) 
was added and the reaction was warmed to room temperature. After 16 hours, the 
reaction was poured into water (20 mL), and the product was extracted with diethyl ether 
(25 mL). The combined organic layers were washed with water (50 mL) and brine (50 
mL), then dried over Na2SO4. The solvent was removed under reduced pressure and the 
product was purified by silica gel chromatography (0-30% EtOAc/hexanes) to afford the 
product as a yellow oil (37 mg, 0.12 mmol, 24%). 1H NMR (500 MHz, CDCl3) δ 7.30 – 
7.27 (m, 2H), 6.98 (d, J = 2.7 Hz, 2H), 6.95 (m, 2H), 6.80 (ddd, J = 8.2, 2.7, 0.6 Hz, 2H), 
2.96 (s, 12H), 0.57 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 150.1, 139.1, 128.6, 122.9, 
118.5, 113.7, 40.8, -2.0. HR-EIMS m/z calculated for C18H27N2Si [M + H]+ :299.1938, 
found: 299.1917. 
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(E)-3-((3-(Dimethylamino)phenyl)dimethylsilyl)-N,N-dimethyl-4-((4-
nitrophenyl)diazenyl) aniline (3.2) 
 
In a 100 mL round bottom flask, compound 3.1 (149 mg, 0.5 mmol) was dissolved in 
aq 2 M HCl (25 mL) and MeOH (10 mL) at 0 °C. 4-Nitrobenzenediazonium 
tetrafluoroborate (119 mg, 0.5 mmol) was separately dissolved in aq 2 M HCl (1 mL) and 
MeOH (5 mL) and added dropwise with an addition funnel, then stirred at 4 °C. After 16 
hours, the reaction was poured into sat’d NaHCO3 (100 mL), and the product was 
extracted with ethyl acetate (3 X 20 mL). The combined organic layers were washed with 
NaHCO3 (50 mL) and brine (50 mL), then dried over Na2SO4. The solvent was removed 
under reduced pressure and the product was purified by silica gel chromatography (0-
20% EtOAc/hexanes) to afford the product as a purple solid (105 mg, 0.23 mmol, 47%). 
1H NMR (500 MHz, CDCl3) δ 8.21 (d, J = 8.9 Hz, 2H), 7.91 (d, J = 9.1 Hz, 1H), 7.60 (d, 
J = 8.9 Hz, 2H), 7.22 (t, J = 7.7 Hz, 1H), 6.95 (d, J = 2.2 Hz, 1H), 6.92 (d, J = 7.2 Hz, 
1H), 6.87 (d, J = 2.8 Hz, 1H), 6.78 – 6.71 (m, 2H), 3.08 (s, 6H), 2.88 (s, 6H), 0.61 (s, 
6H). 13C NMR (126 MHz, CDCl3) δ 157.0, 152.5, 150.2, 148.3, 147.2, 145.3, 140.0, 
128.5, 124.7, 123.0, 122.9, 118.6, 118.2, 117.4, 113.6, 113.1, 40.9, 40.3, -0.2. HR-EIMS 
m/z calculated for C24H30N5O2Si [M + H]+: 488.2163, found: 488.2143. 
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Bis(2,4-dibromophenyl)amine (3.3)  
 
 
In a 1 L round bottom flask, diphenylamine (5 g, 29.9 mmol) was dissolved in 
acetone (225 mL) at room temperature. The temperature was lowered to 0 °C, then NBS 
(23.2 g) was added in small portions. After 15 minutes, H2O (225 mL) was added to the 
reaction and the white solid was filtered and washed with 50/50 acetone/H2O (400 mL). 
Finally, the white solid was recrystallized in toluene (300 mL) giving 3 as a white solid 
(9.75 g, 20.1 mmol, 69%). 1H NMR (500 MHz, C6D6) δ 7.45 (d, J = 2.2 Hz, 2H), 6.88 
(dd, J = 8.7, 2.2 Hz, 2H), 6.39 (d, J = 8.7 Hz, 2H), 6.15 (s, 1H). 13C NMR (126 MHz, 
C6D6) δ 139.0, 135.6, 131.3, 119.2, 115.3, 114.2. HR-EIMS m/z calculated for 
C12H8Br4N [M + H]+: 485.7344, found: 485.7339. 
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2,4-Dibromo-N-(2,4-dibromophenyl)-N-(4-methoxybenzyl)aniline (3.4) 
 
In a 500 mL round bottom flask, compound 3.3 (9.75 g, 20.1 mmol) was dissolved in 
THF (250 mL) at 0 °C. Sodium hydride (2.4 g, 100 mmol) was added to the reaction in 
small portions. After one hour, p-methoxybenzyl chloride (PMB-Cl) (4.1 mL, 30.1 
mmol) was added, then the reaction was warmed to room temperature and stirred for 72 
hours. The solvent was then removed under reduced pressure. The resulting solid was 
triturated in MeOH (10 mL) and the product was collected by filtration (10.8 g, 17.9 
mmol, 89%). 1H NMR (500 MHz, CDCl3) δ 7.74 (d, J = 2.0 Hz, 2H), 7.40 (d, J = 8.4 Hz, 
2H), 7.36 – 7.21 (m, 2H), 6.83 (d, J = 8.5 Hz, 4H), 4.72 (s, 2H), 3.78 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 158.8, 145.8, 136.7, 131.1, 128.8, 128.7, 126.5, 122.0, 117.2, 114.0, 
56.1, 55.2. HR-EIMS m/z calculated for C20H14Br4NO [M - H]+: 603.7762, found: 
603.7756. The NMR is consistent with previously reported values.97 
 
 
 
 
 
 
 
 
 
 
 
 166 
 
 
 
 
2,4-Dibromo-N-(2,4-dibromophenyl)-N-(4-methoxybenzyl)aniline (3.5). 
 
 
In a 100 mL oven-dried round bottom flask, compound 3.4 (1.2 g, 1.99 mmol) was 
dissolved in anhydrous diethyl ether (25 mL) at room temperature and then cooled to 0 
°C. n-BuLi (2.6 mL of 1.6 M) was added drop-wise to the reaction. After 1 hour, 
dichlorodimethylsilane (460 mg, 3.6 mmol) was added and the reaction mixture was 
warmed to room temperature. After 16 hours, the product was extracted with ether (50 
mL), washed with water (50 mL) and brine (50 mL), and finally purified with silica gel 
chromatography (0-50% DCM/hexanes) to afford a white solid (515 mg, 1 mmol, 50%). 
1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 2.5 Hz, 2H), 7.30 (dd, J = 9.0, 2.5 Hz, 2H), 
7.11 (d, J = 8.7 Hz, 2H), 6.90 – 6.85 (m, 2H), 6.78 (d, J = 9.0 Hz, 2H), 5.09 (s, 2H), 3.81 
(s, 3H), 0.47 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 158.9, 148.4, 135.8, 133.2, 128.7, 
127.4, 124.5, 118.3, 114.5, 113.9, 55.6, 55.5, -0.8. HR-EIMS m/z calculated for 
C22H22Br2NOSi [M + H]+: 503.9811, found: 503.9805.  
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2,8-Di(azetidin-1-yl)-5-(4-methoxybenzyl)-10,10-dimethyl-5,10 
dihydrodibenzo[b,e][1,4] azasiline (3.6) 
 
 
In a 15 mL sealed tube, compound 3.5 (200 mg, 0.4 mmol), Pd2(dba)3 (18.3 mg, 0.02 
mmol), BINAP (25 mg 0.04 mmol), sodium tert-butoxide (92 mg, 0.96 mmol) and 
azetidine (50 mg, 0.87 mmol) were dissolved in anhydrous toluene (10 mL). The reaction 
tube was flushed with argon, then heated to 80 °C for 24 hours. The reaction was filtered 
through Celite and the product was purified with silica gel chromatography (0-30% 
EtOAC/hexanes) to afford a yellow-tinted solid (129 mg, 0.28 mmol, 71%). 1H NMR 
(500 MHz, CDCl3) δ 7.17 (d, J = 8.6 Hz, 2H), 6.88 – 6.84 (m, 2H), 6.78 (d, J = 8.9 Hz, 
2H), 6.60 (d, J = 2.9 Hz, 2H), 6.41 (dd, J = 8.9, 2.9 Hz, 2H), 5.05 (s, 2H), 3.83 (t, J = 7.1 
Hz, 8H), 3.80 (s, 3H), 2.33 (p, J = 7.1 Hz, 4H), 0.45 (d, J = 3.2 Hz, 6H). 13C NMR (126 
MHz, CDCl3) δ 158.5, 146.0, 142.8, 131.1, 127.6, 122.1, 116.5, 115.8, 114.4, 114.2, 
55.6, 55.4, 53.2, 17.3, -0.7. HR-EIMS m/z calculated for C28H34N3OSi [M + H]+: 
456.2466, found: 456.2436. 
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Bis(2-fluorophenyl)amine (3.8) 
 
 
In a 100 mL round bottom flask equipped with a reflux condenser, 2-fluoroaniline (2 
g, 18 mmol), 1-bromo-2-fluorobenzene (3.5 g, 19.8 mmol), Pd2(dba)3 (833 mg, 0.9 
mmol), Xantphos (1 g, 1.8 mmol), and sodium tert-butoxide (2.1 g, 21.8 mmol) were 
dissolved in anhydrous toluene (15 ml). The reaction was refluxed at 110 °C.  After 16 
hours, the reaction was filtered through Celite and the solvent was removed under 
reduced pressure. The product was purified with silica gel chromatography (0-5% 
DCM/hexanes) to afford a clear oil (3.3 g, 16 mmol, 89%). 1H NMR (500 MHz, CDCl3) 
δ 7.33 (dt, J = 8.3, 1.4 Hz, 2H), 7.19 – 7.12 (m, 2H), 7.12 – 7.06 (m, 2H), 6.98 – 6.91 (m, 
2H), 5.90 (s, 1H). 19F NMR (471 MHz, CDCl3) δ -131.24 (ddd, J = 11.6, 8.6, 4.9 Hz). 13C 
NMR (126 MHz, CDCl3) δ 153.7 (d, JCF = 242.2 Hz), 130.7 (d, JCF = 11.1 Hz), 124.4 (d, 
JCF = 3.8 Hz), 121.7 (d, JCF = 7.3 Hz), 118.3 (d, JCF = 1.8 Hz), 115.8 (d, JCF = 19.2 Hz). 
HR-EIMS m/z calculated for C12H10F2N [M + H]+: 206.0776, found: 206.0776. 
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Bis(2,4-dibromo-6-fluorophenyl)amine (3.9) 
 
In a 50 mL round bottom flask, compound 3.8 (2 g, 9.74 mmol) was dissolved in 
acetic acid (20 mL). The reaction temperature was raised to 110 °C, followed by the 
addition of bromine (2.1 mL, 58.4 mmol). After 10 minutes, the reaction was cooled to 
room temperature to allow for crystallization of the product. The product was filtered and 
washed with acetic acid (60 ml) and H2O (200 mL) to afford a white solid (4.21 g, 8.1 
mmol, 83%). 1H NMR (500 MHz, CDCl3) δ 7.57 – 7.50 (m, 2H), 7.18 (dd, J = 10.6, 1.9 
Hz, 2H), 5.64 (s, 1H). 19F NMR (471 MHz, CDCl3) δ -119.23 (d, J = 10.4 Hz). 13C NMR 
(126 MHz, CDCl3) δ 154.4 (dd, JCF = 254.0, 2.3 Hz), 130.6 (d, JCF = 2.8 Hz), 128.8 (dd, 
JCF = 11.7, 2.0 Hz), 119.0 (d, JCF = 23.5 Hz), 116.9 – 116.4 (m), 114.4 – 114.1 (m). HR-
EIMS m/z calculated for C12H6Br4F2N [M + H]+: 521.7155, found: 521.7135. 
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2,4-Dibromo-N-(2,4-dibromo-6-fluorophenyl)-6-fluoro-N-(4-methoxybenzyl)aniline 
(3.10) 
 
In a 100 mL round bottom flask, compound 3.9 (2 g, 3.9 mmol) and 15-Crown 5 (1.6 
mL, 7.8 mmol) were dissolved in THF (40 mL). Sodium hydride (120 mg, 5 mmol) was 
added to the reaction in small portions. After 1 hour, p-methoxybenzyl chloride (529 ml, 
5.85 mmol) was added to the solution and refluxed at 75 °C. After 24 hours, the reaction 
was poured into brine (100 mL) and extracted with EtOAc (3 X 50 mL). The combined 
organic layers were washed with brine (100 mL) and dried over sodium sulfate. The 
solvent was removed under reduced pressure and the product was purified by silica gel 
chromatography (0-100% DCM/hexanes) to afford a white solid (2.07 g, 3.22 mmol, 
82%). 1H NMR (500 MHz, CDCl3) δ 7.47 – 7.44 (m, 2H), 7.41 (d, J = 8.6 Hz, 2H), 7.11 
(dd, J = 10.9, 2.2 Hz, 2H), 6.80 – 6.72 (m, 2H), 4.82 (s, 2H), 3.75 (s, 3H). 19F NMR (471 
MHz, CDCl3) δ -111.59. 13C NMR (126 MHz, CDCl3) δ 160.1 (d, JCF = 256.5 Hz), 
159.6, 133.1 (d, JCF = 11.9 Hz), 132.2 (d, JCF = 3.4 Hz), 129.7, 128.4, 123.4 (d, JCF = 3.9 
Hz), 119.6 (d, JCF = 25.3 Hz), 117.8 (d, JCF = 11.0 Hz), 113.7 , 56.7 (t, JCF = 5.67 Hz), 
55.3. HR-EIMS m/z calculated for C20H12Br4F2NO [M - H]+: 639.7574, found: 
639.7564. 
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2,8-Dibromo-4,6-difluoro-5-(4-methoxybenzyl)-10,10-dimethyl-5,10-
dihydrodibenzo[b,e][1,4] azasiline (3.11) 
 
In a 50 mL oven-dried round bottom flask, compound 3.10 (642 mg, 1 mmol) was 
dissolved in anhydrous diethyl ether (25 mL) at room temperature and then cooled to -78 
°C. n-BuLi (0.96 ml of 1.6 M, 2.4 mmol) was added drop-wise to the reaction. After 1 
hour, dichlorodimethylsilane (645 mg, 5 mmol) was added and the reaction mixture was 
warmed to room temperature. After 4 hours, the product was extracted with ether (25 
mL) and then washed with water (50 mL) and brine (50 mL) and dried over Na2SO4. The 
solvent was removed under reduced pressure and the product was purified by silica gel 
chromatography (0-50% DCM/hexanes). The resulting white solid was washed with 
MeOH (2 mL) and filtered to afford the product (114 mg, 0.21 mmol, 21%). 1H NMR 
(500 MHz, CDCl3) δ 7.30 (dd, J = 11.7, 2.2 Hz, 2H), 7.21 (d, J = 2.1 Hz, 2H), 6.80 – 6.73 
(m, 2H), 6.71 – 6.62 (m, 2H), 4.86 (s, 2H), 3.70 (s, 3H), 0.46 (s, 3H), -0.26 (s, 3H). 19F 
NMR (471 MHz, CDCl3) δ -113.89 (d, J = 11.6 Hz).13C NMR (126 MHz, CDCl3) δ 
159.3, 156.2, 154.2, 137.9 (d, JCF = 6.4 Hz), 134.0, 131.1 (d, JCF = 4.0 Hz), 130.6, 129.4, 
121.0 (d, JCF = 24.8 Hz), 116.0 (d, JCF = 7.6 Hz), 113.8, 58.0 (t, JCF = 9.2 Hz), 55.4. HR-
EIMS m/z calculated for C22H20Br2F2NOSiNa [M + Na]+: 561.9442, found: 561.9432. 
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2,8-Di(azetidin-1-yl)-4,6-difluoro-5-(4-methoxybenzyl)-10,10-dimethyl-5,10 
dihydrodibenzo [b,e][1,4]azasiline (3.12) 
 
 
In a 15 mL sealed tube, compound 3.11 (50 mg, 0.093 mmol), Pd2(dba)3 (4.2 mg, 
0.0046 mmol), BINAP (5.8 mg, 0.009 mmol), sodium tert-butoxide (21 mg, 0.22 mmol) 
and azetidine (21 mg, 0.37 mmol) were dissolved in anhydrous toluene (2 mL). The 
reaction tube was flushed with argon, then heated to 110 °C. After 24 hours, the reaction 
mixture was filtered through Celite.  The solvent was removed under reduced pressure 
and the product was purified by silica gel chromatography (0-30% EtOAC/hexanes) to 
afford a light yellow solid (46 mg, 0.093 mmol, quantitative). 1H NMR (500 MHz, 
CDCl3) δ 6.71 – 6.53 (m, 4H), 6.29 (dd, J = 13.9, 2.5 Hz, 2H), 6.13 (d, J = 2.5 Hz, 2H), 
4.71 (s, 2H), 3.85 (t, J = 7.2 Hz, 8H), 3.69 (s, 3H), 2.34 (p, J = 7.5  Hz, 4H), 0.36 (s, 3H), 
-0.47 (s, 3H). 19F NMR (471 MHz, CDCl3) δ -117.72 (d, J = 13.9 Hz). 13C NMR (126 
MHz, CDCl3) δ 158.9, 156.3 (d, JCF = 249.5 Hz), 149.2 (d, JCF = 8.6 Hz), 133.2, 130.9, 
130.5 (t, JCF = 3.6 Hz), 113.4, 110.1 (d, JCF = 3.1 Hz), 101.6 (d, JCF = 24.9 Hz), 58.5 (t, 
JCF = 7.4 Hz), 55.3, 52.9, 17.0, -1.0, -2.6. HR-EIMS m/z= calculated for 
C28H32F2N3OSi [M + H]+: 492.2277, found: 492.2257. 
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2,8-Di(azetidin-1-yl)-4,6-difluoro-5-(4-methoxybenzyl)-10,10-dimethyl-5,10-
dihydrodibenzo[b,e][1,4]azasiline (3.13), ASiFluor710 
 
 
In a 25 mL round bottom flask, compound 3.12 (20 mg, 0.04 mmol) was dissolved in 
MeOH (10 mL) at 0 °C. Iodine (21 mg, 0.08 mmol) was separately dissolved in MeOH (5 
mL) and added to the reaction. After 20 minutes, the resulting green solid was collected 
by filtration and washed with hexane (10 mL). The product can used without further 
purification (13 mg, 0.028 mmol, 70%). To increase solubility 10 mg (0.021 mmol) was 
eluted through a reverse phase C18 column (20-85% ACN/H2O, 0.1% TFA) to afford the 
TFA salt (4 mg, 0.008 mmol, 40%). 1H NMR (500 MHz, CD3CN) δ 6.83 (d, J = 2.3 Hz, 
2H), 6.39 (dd, J = 12.3, 2.3 Hz, 2H), 4.62 – 4.20 (m, 8H), 2.53 (p, J = 8.0 Hz, 4H), 0.48 
(s, 6H). 19F NMR (471 MHz, CD3CN) δ -105.67 (d, J = 12.4 Hz). 13C NMR (126 MHz, 
CD3CN) δ 166.5 (d, JCF = 272.2 Hz), 157.3 (d, JCF = 14.2 Hz), 140.1 (d, JCF = 2.2 Hz), 
134.9 (d, JCF = 7.1 Hz), 120.5, 100.2 (d, JCF = 25.2 Hz), 55 – 54 (m), 16.4, -1.0. HR-
EIMS m/z [M] + calculated for C20H22F2N3Si [M + H]+: 370.1546, found: 370.1545.  
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1-(7-(Azetidin-1-yl)-1-methyl-3H-phenoxazin-3-ylidene)azetidin-1-ium (3.13′) 
 
In a 50 mL round bottom flask, compound 3.13 (6 mg, 0.01 mmol) was dissolved in 
acetonitrile (10 mL) and PBS (10 mL) and stirred in the dark at room temperature. After 
48 hours, the reaction was poured into brine (50 mL) and extracted with acetonitrile (3 X 
20 mL). The combined organic layers were washed with brine (50 mL) and dried over 
sodium sulfate. The solvent was removed under reduced pressure and the product was 
purified by preparatory HPLC (0-65% 0.1% TFA ACN/H2O) to afford a blue solid (>1 
mg). 1H NMR (500 MHz, MeOD) δ 7.75 (d, J = 9.2 Hz, 1H), 6.87 (dd, J = 9.2, 2.4 Hz, 
1H), 6.83 – 6.79 (m, 1H), 6.46 (d, J = 2.4 Hz, 1H), 6.40 (d, J = 2.4 Hz, 1H), 4.52 – 4.32 
(m, 8H), 2.64 – 2.49 (m, 7H). HR-EIMS m/z calculated for C19H20N3O M+: 306.1601, 
found: 306.1596.  
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1-(3-Bromo-5-methylphenyl)azetidine (3.14) 
 
 
In a 75 mL sealed pressure tube, 2,5-dibromotoluene (4 g, 16 mmol), azetidine (457 
mg , 8 mmol), Pd2(dba)3 (366 mg, 0.4 mmol), BINAP (498 mg, 0.8 mmol), and sodium 
tert-butoxide (921 mg, 9.6 mmol) were dissolved in anhydrous toluene (62 mL). The 
reaction was heated to 110 °C for 24 hours. The reaction was then filtered through Celite 
and the solvent was removed under reduced pressure. The product was purified with 
silica gel chromatography (0-30% EtOAc/hexanes) to afford a white solid (1.2 g, 5.3 
mmol, 66%). 1H NMR (500 MHz, CDCl3) δ 6.68 (s, 1H), 6.39 – 6.35 (m, 1H), 6.14 (s, 
1H), 3.85 (t, J = 7.2 Hz, 4H), 2.35 (p, J = 7.5 Hz , 2H), 2.25 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 153.1, 140.5, 122.8, 120.9, 111.3, 110.6, 52.3, 21.4, 16.9. HR-EIMS m/z 
calculated for C10H13BrN [M + H]+: 226.0226, found: 226.0197. 
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Bis(3-(azetidin-1-yl)-5-methylphenyl)dimethylsilane (3.15) 
 
In a 100 mL oven-dried round bottom flask, compound 3.14 (500 mg, 2.21 mmol) 
was dissolved in anhydrous diethyl ether (50 mL) and anhydrous THF (1 mL) at room 
temperature and then cooled to 0 °C. n-BuLi (1.76 ml of 2.5 M, 4.4 mmol) was added 
drop-wise to the reaction. After 1 hour, dichlorodimethylsilane (171 mg, 1.3 mmol) was 
added and the reaction was warmed to room temperature. After 16 hours, the reaction 
was poured into water (20 mL), and the product was extracted with diethyl ether (25 mL). 
The combined organic layers were washed with water (50 mL) and brine (50 mL), then 
dried over Na2SO4. The solvent was removed under reduced pressure and the product was 
purified by silica gel chromatography (0-50% DCM/hexanes) to afford a yellow solid 
(170 mg, 0.49 mmol, 44%). 1H NMR (500 MHz, CDCl3) δ 6.72 (s, 2H), 6.44 (d, J = 2.2 
Hz, 2H), 6.38 – 6.25 (m, 2H), 3.85 (t, J = 7.2 Hz, 8H), 2.33 (p, J = 7.5 Hz, 4H), 2.28 (s, 
6H), 0.48 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 151.8, 138.9, 137.9, 124.4, 114.2, 
113.1, 52.6, 21.8, 17.2, -2.0. HR-EIMS m/z calculated for C22H31N2Si [M + H]+: 
351.2251, found: 351.2261. 
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Bis(5-(azetidin-1-yl)-2-bromo-3-methylphenyl)dimethylsilane (3.16) 
 
In a 50 ml round bottom flask, 3.15 (170 mg, 0.48 mmol) was dissolved in 
dichloromethane (19 mL) at 0 °C. NBS (172 mg, 0.97 mmol) was separately dissolved in 
dichloromethane (1 mL) and added dropwise to the reaction. After 15 minutes, the 
solvent was removed under reduced pressure and the product was purified by silica gel 
chromatography (0-20% EtOAc/hexanes) to afford a white solid (170 mg, 0.35 mmol, 
74%). 1H NMR (500 MHz, CDCl3) δ 6.39 (d, J =2.8 Hz, 2H), 6.33 (d, J= 2.7, 2 H), 3.80 
(t, J = 7.2 Hz, 8H), 2.37 – 2.27 (m, 10H), 0.71 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 
150.8, 140.2, 138.2, 120.5, 118.4, 115.0, 52.6, 24.3, 17.1, -0.2. HR-EIMS m/z calculated 
for C22H29Br2N2Si [M + H]+: 509.0441, found: 509.0457. 
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2,8-Di(azetidin-1-yl)-5-(4-methoxybenzyl)-4,6,10,10-tetramethyl-5,10-
dihydrodibenzo [b,e][1,4]azasiline (3.17) 
 
In a 15 mL sealed tube, compound 3.16 (150 mg, 0.3 mmol), Pd2(dba)3 (13.7 mg, 
0.015 mmol), BINAP (18.4 mg 0.03 mmol), sodium tert-butoxide (68 mg, 0.71 mmol) 
and 4-methoxybenzylamine (49 mg, 0.35 mmol) were dissolved in anhydrous toluene (3 
mL). The reaction tube was flushed with argon, then heated to 110 °C. After 48 hours the 
reaction mixture was filtered through Celite.  The solvent was removed under reduced 
pressure and the product was purified by silica gel chromatography (0-20% 
EtOAc/hexanes) to afford a yellow solid (50 mg, 0.1 mmol, 33%). 1H NMR (500 MHz, 
CDCl3) δ 6.61 (d, J = 8.6 Hz, 2H), 6.51 (d, J = 8.6 Hz, 2H), 6.37 (d, J = 2.6 Hz, 2H), 6.34 
(d, J = 2.7 Hz, 2H), 4.15 (s, 2H), 3.85 (t, J = 7.1 Hz, 8H), 3.72 (s, 3H), 2.40 (s, 6H), 2.33 
(p, J = 7.0 Hz, 4H), 0.31 (s, 3H), -0.24 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 158.8, 
148.6, 144.9, 134.5, 134.1, 132.0, 130.2, 115.8, 113.8, 113.2, 61.8, 55.4, 52.9, 19.6, 17.2, 
-0.4, -1.5. HR-EIMS m/z calculated for C30H38N3OSi [M + H]+: 484.2779, found: 
484.2762. 
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1-(8-(Azetidin-1-yl)-4,6,10,10-tetramethyldibenzo[b,e][1,4]azasilin-2(10H)-
ylidene)azetidin-1-ium (3.18), ASiFluor730 
 
In a 25 mL round bottom flask, compound 3.17 (8.5 mg, 0.018 mmol) was dissolved 
in MeOH (1 mL) at 0 °C. Iodine (4.4 mg, 0.176 mmol) was separately dissolved in 
MeOH (5 mL) and then added to the reaction. After 15 minutes, the solvent was removed 
under reduced pressure and the product was purified by silica gel chromatography (0-
20% MeOH/DCM). The product was further purified with preparatory HPLC (20-85% 
0.1% TFA ACN/H2O) to afford a green solid (3 mg, 0.006 mmol, 36%). 1H NMR (500 
MHz, MeOD) δ 6.88 (d, J = 2.6 Hz, 2H), 6.59 – 6.55  (m, 2H), 4.47 (t, J = 7.7 Hz, 8H), 
2.57 (p, J = 7.5 Hz, 4H), 2.50 (s, 6H), 0.44 (s, 6H). 13C NMR (126 MHz, MeOD) δ 155.2, 
154.2, 144.4, 140.5, 121.3, 115.0, 53.7, 19.8, 16.7, -1.4. HR-EIMS m/z calculated for 
C22H28N3Si M+: 362.2047, found: 362.2043. 
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NMR Spectra 
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CHAPTER IV: 
Discussions and Future Directions 
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Since the first discovery of fluorescence, researchers have used fluorescent probes to 
interrogate important biological and chemical processes.109,110 The arsenal of fluorescent 
probes in modern science includes numerous fluorescent proteins, organic dyes, and more 
recently, quantum dots.111 Efforts to refine fluorescent techniques and probes, coupled 
with advances in microscopy, have positioned these tools at the vanguard of scientific 
progress.  While fluorescent probes have made great strides in recent history, important 
limitations still exist, especially in regards to solubility, photostability, and light 
penetrance. Regardless of type, NIR fluorescent probes produce the cleanest signal, 
owing to the high penetrance of NIR light.22,27 However, as discussed in CHAPTER I, 
current NIR probes are far from perfect. Most NIR fluorophores have low aqueous 
solubility, due to their extended π-conjugation. Addition of polar sulfonates could impart 
aqueous solubility, but often at the expense of membrane permeability. However, Rusha 
and Miller showed that aqueous solubility and membrane permeability are not mutually 
exclusive. Using AcOTFMB, they delivered a dansyl-sulfonate fluorophore into live cells 
with intact membranes.48  
 
In CHAPTER II, I aimed to expand the repertoire of TFMB-based sulfonate 
protecting groups to include biocompatible chemically-labile triggers, with the goal of 
extending the applications of sulfonated molecules to living cells. Specifically, I am 
interested in creating reductively labile protecting groups that can exploit the high 
reductive activity of cytosolic GSH. To that end, I created two reductively-labile 
protecting groups (RLPG): MeSSTFMB and MeSSTFMP. The synthetic conditions to 
access both MeSSTFMB and MeSSTFMP were mild and straightforward..  MeSSTFMP 
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resulted in a high percentage of sulfonate delivery into cells. MeSSTFMB, while 
delivering a lower percentage of sulfonates when compared to MeSSTFMP, did not show 
any appreciable toxicity in Hela cells, demonstrating its potential in long exposure 
experiments.  
 
MeSSTFMP-Dan achieved complete cleavage within three minutes in vitro and 
yielded bright diffusive fluorescence in Hela cells. Moreover, the observed LD50 for 
MeSSTFMP-Dan than AcOTFMB-Dan.  I hypothesize thioquinone methides are 
intrinsically less toxic than quinone methides, which tend to form nucleophilic adducts. 
Thioquinone methides preferentially form the two-electron reduction product, which may 
impart transient oxidative stress, whereasalkylation can impart irreversible call damage 
.48,86,87  If true, then perhaps the toxicity of AcOTFMB could be decreased if the acetoxy 
group is replaced with a thioester group (Figure 4.1). 
 
The rate of (thio)methide generation may also contribute to toxicity. Presumably, 
reduction of MeSSTFMB and MeSSTFMP would form p-thioquinone methides with 
similar toxicity. However, as previously observed, the slow cleaving MeSSTFMB-Dan 
was not cytotoxic, implying a correlation between cleavage rate and toxicity.  
 
To elucidate the source(s) of cytotoxicity, one could make two comparisons. First, 
compare the toxicity between different esterase-labile TFMB groups. Since structure 
dictates enzyme recognition, different esters should cleave at different rates, which in 
turn generates quinone methides at different rates. Second, compare the toxicity of the 
proposed S-AcOTFMB and AcOTFMB. Assuming their cleavage rates are similar, this 
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would allow one to directly compare the toxicity between thioquinone methide and 
quinone methide.   
 
 
  
Figure 4.1: Thioester AcOTFMB (S-AcOTFMB) could be less cytotoxic. AcOTFMB 
and S-AcOTFMB form a quinone methide and thioquinone methide, respectively. The 
thioquinone methide is potentially less cytotoxic than the quinone methide  
 
 
 
 
Shortly after the full characterization of MeSSTFMP, I sought to append it to other 
sulfonated fluorophores. Given the popularity of cyanine fluorophores, I was interested in 
synthesizing the bis-MeSSTFMP-Cy5. However, I quickly realized the inherent 
difficulties in protecting multiple sulfonates simultaneously. Sulfonate-esters are 
generally synthesized through sulfonyl chloride intermediates, which are prone to 
hydrolysis.112–114 Fully aware of their instability, the Cy5 sulfonyl chloride was used 
immediately after its synthesis and solvent removal. Disturbingly, esterification with 
MeSSTFMP still resulted in partial or complete hydrolysis of the sulfonyl chlorides, 
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despite my best efforts in maintaining an anhydrous environment. Mass spectrometry 
analysis revealed only trace amounts of the desired bis-sulfonate ester and the major 
product as the mono-sulfonate ester (Figure 4.2). Through optimization, the desired bis-
MeSSTFMP-Cy5 was eventually isolated, albeit with low yield. Hence, inefficient 
synthetic routes to access sulfonate esters remain a major obstacle to the applications of 
RLPGs.  
 
 
Figure 4.2: Protection of sulfo-Cy5 with MeSSTFMP typically yields the monoester 
as the major product. Sulfonyl chlorides are prone to hydrolysis. Esterification of 
multiple sulfonates via sulfonyl chloride intermediates generally yields the mono-ester 
and diester as the major and minor product, respectively. 
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Sulfonyl chlorides are unstable and easily hydrolyzed into sulfonates.115 Thus, the 
sulfonate-ester should either be formed at the beginning or the end of synthesis. 
Sulfonate-esters formed at the beginning must withstand harsh synthetic conditions, 
which are presumably incompatible with our RLPGs that are cleaved under mild 
biological conditions. Forming the ester at the end is plausible, though this approach 
comes with limitations, as not all compounds are stable under chlorination conditions. 
Moreover, as previously observed, trace amounts of moisture can completely quench the 
reaction. Further, purification of sulfonated compounds could be more difficult due to 
their polarity. 
 
Clearly, neither method is ideal for appending RLPGs to compounds with multiple 
sulfonates. However, a third option is possible, where a chemically stable protecting 
group is first installed, followed by its conversion into a RLPG. For example, mono-
sulfonated intermediates could be first converted to sulfonate esters with a chemically-
stable RLPG precursor, such as 4-bromo-TFMP. Early esterification simplifies the 
reaction and purification conditions and eliminates the need for simultaneous 
esterification of multiple sulfonates. After total synthesis of the molecule, the aryl 
bromide could be converted to a thiosulfate group (Bunte salt), which, in turn, could form 
a disulfide (Figure 4.3).116–119 Since the thiosulfonate ester to disulfide conversion 
proceeds via a SN2 mechanism, it should not lead to deprotection of the sulfonates.116  
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Figure 4.3: Accessing RLPG protected sulfo-Cy5 via a Bunte salt intermediate. 
Mono-sulfonated intermediates are chlorinated and esterified with a chemically stable 
protecting group. After the complete synthesis of the parent molecule, the aryl-bromide is 
converted into a Bunte salt and then into a disulfide to yield the RLPG. 
 
 
 
 
 To deliver the polar anionic dansyl sulfonate fluorophore in the living cells, I 
synthetized reductively-labile protecting groups. As predicted, both RLPGs successfully 
drove intracellular delivery of dansyl-sulfonate. However, the solubility of MeSSTFMB-
Dan was rather low, aggregation on cell membranes was visible at concentrations as low 
as 10 µM, reflecting the importance of the balance between hydrophilicity and 
hydrophobicity. Given the modularity of the TFMP and TFMB, one would expect that 
polarity could be optimized by the attachment of a hydrophilic group. While true, a quick 
survey of commercially available thiosulfonate S-esters, the key thiol group donor in our 
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synthetic schemes, quickly reveals their scarcity. Besides S-methyl or S-ethyl, other 
sulfonate S-esters are either unavailable or cost prohibitive. Given their importance in 
generating disulfides, I propose two feasible routes to access thiosulfonate S-esters. 
 
Both routes undergo SN2 reactions to form the desired thiosulfonate S-esters. 
However, the first route utilizes toluene-thiosulfonate, whereas, the second route, utilizes 
thiolates as nucleophiles (Figure 4.4). The generality of these methods should greatly 
improve the feasibility of accessing different disulfides, despite the commercial shortage 
of thiosulfonate S-esters. Besides solubilizing groups, one could also use these methods 
to append a myriad of linkers and targeting moieties on TFMP and TFMB to form a 
library of RLPGs.  
 
 
 
Figure 4.4: Different ways to access thiosulfonates intermediates. Reaction between 
p-toluenethiosulfonate and an alkyl halide (a) or tosyl chloride and a thiol (b) affords the 
thiosulfonate ester, which then can react to form RLPGs. For clarity, the R-group is 
depicted as a propyl group. 
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In CHAPTER III, I proceeded to address the deficiencies of current NIR 
fluorophores. Most NIR fluorophores have low aqueous solubility without solubilizing 
groups such as sulfonates. However, the ginormous ICG fluorophore is only sparingly 
soluble in water, even with two sulfonates.90–92  Clearly, molecular size can override the 
solubilizing effects of sulfonates.  Moreover, the selection of NIR fluorescent probes is 
generally limited to cyanines, which have poor photostability. To combat the adverse 
effect of molecule size, while also achieving NIR fluorescence and maintaining high 
photostability, I substituted oxygen with silicon in oxazine fluorophores to form 
azasilines.  
 
In total, I attempted to synthesize three different azasiline derivatives: an azetidinyl 
(unsubstituted), a difluoro (ASiFluor710), and a dimethyl (ASiFluor730) derivative. Only 
the ASiFluor710 and ASiFluor730 could be synthesized and isolated, presumably due to 
the electron-donating effects of the R-groups. It is worth noting that ASiFluor710 was 
isolated without purification and thus, could be synthesized in large scale. Unfortunately, 
the fluorine groups on ASiFluor710 may have decreased aqueous stability. Although the 
precise mechanism of degradation wasn’t determined, the formation of an oxazine 
implies that degradation was initiated by the replacement of fluorine by water 
(hydrolysis) (Figure 4.5).120 Potentially, ASiFluor710 could be stabilized by replacing 
fluorine with a weaker leaving group, such as chlorine.  
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Not all fluorinated compounds are unstable in water. Stable fluorinated fluorescein 
and Si-rhodamines have been reported.55,121 Interestingly, these reports show that fluorine 
groups can change the photophysical properties of the dye molecule when installed in 
certain positions of the ring. Perhaps, changing fluorination positions on the azasiline can 
promote aqueous stability.  
 
 
 
Figure 4.5: Possible initiation step of ASiFluor710 degradation. Nucleophilic 
aromatic substitution of fluorine by water ultimately leads to the formation of a 
methylated oxazine. 
 
 
 
 
ASiFluor730 was photostable and showed impressive bathochromic shifts of over 80 
nm compared to Oxazine 1. It also had a noteworthy quantum yield of 0.11, only 22% 
lower than oxazine 1 (0.14). Besides Oxazine 1, other oxazine derivatives that have 
higher quantum yields and/or longer emission wavelengths have been reported (Figure 
4.6). For example, some rigidified oxazines have quantum yields of ≥0.20 and emission 
wavelengths of up to 717 nm.94,122 With that in mind, the optical properties of azasilines 
could be further optimized through modification. 
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        MR-121  
  666ex/679em        664ex/681em                  703ex/717em 
        ΦFl = 0.2              ΦFl = 0.24                      ΦFl = 0.08 
 
Figure 4.6: Optical properties of oxazine derivatives. Substituents alters the 
fluorescence and quantum yield of oxazines. The name (if available), excitation and 
emission wavelengths, and fluorescence quantum yield are listed below each molecule. 
 
 
 
 
 The increase in quantum yield after the addition of 0.05% Tween 20 implies the 
addition of polar groups could improve quantum yields in aqueous media. The azasiline 
scaffold has multiple sites amenable to functionalization. For example, the key aryl halide 
intermediate can undergo palladium-catalyzed coupling with amines. In CHAPTER III, 
I chose to install azetidines with the intention of increasing quantum yields. However, 
palladium-catalyzed coupling of aryl halides is not limited to azetidines; other substituted 
amines, such as ones that endow aqueous solubility are also compatible. Primary amines 
may also participate in palladium-catalyzed coupling to form secondary aryl amines, 
which could be further modified to form the final tertiary amines (Figure 4.7).123,124  
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Figure 4.7: Modifying azasilines via aryl-halide intermediates. Palladium-catalyzed 
coupling of secondary or primary amines followed by N-alkyl or arylation yields 
functionalized azasilines.  
 
 
 
 
Unlike oxygen, silicon is a group 14 element that can form four bonds without 
gaining a formal charge. Two of the four bonds are used to form the azasiline, leaving 
two for potential modifications. While commercially available dichloro-silane derivatives 
are limited, 3-chloropropylmethyldichlorosilane is available. Cyclization using 3-
chloropropylmethyldichlorosilane yields an azasiline with a chloropropyl chain directly 
attached to the silicon. Potentially, the chloride could be replaced by an iodide with the 
Finklestein reaction, providing another site for modification.120 Alkyl iodides are 
excellent leaving groups; simple SN2 displacement should readily yield the azasilines 
bearing affinity ligands, such as HaloTag, SNAP-Tag, CLIP-Tag, and azido groups to 
support Click chemistry (Figure 4.8).125–127  
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Figure 4.8: Potential R-group attachments on silicon of ASiFluors. Chloropropyl 
group installed on ASiFluors could be converted to an iodopropyl group and then to an 
azido group (N3). Subsequent reaction with an alkyne (Click-chemistry) affords a 
functionalized R-group or tagged protein.    
 
 
 
 
ASiFluor710 was easily synthesized, but labile to hydrolysis. Serendipitously, the 
electrophilic fluorine could potentially be used as yet another site for modification. The 
PMB-protected ASiFluor710 could react with carbanions to form alkylated azasilines. 
Carbon nucleophiles are not as common other nucleophiles, thus the modulatory could be 
limited. However, that position could be sulfonated via a lithiated carbanion intermediate 
(Scheme 4.1).128 Finally, while modifications could be performed individually, all three 
sites could be utilized simultaneously for maximum versatility (Figure 4.9). One could 
install azetidines, an azido group, and sulfonates to concomitantly enhance the quantum 
yield, use Click Chemistry, and maximize aqueous solubility, respectively. 
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Scheme 4.1: Purposed sulfonation method for ASiFluors. Lithiated methyl sulfonate 
ester replaces the fluorine groups on an ASiFluor710 precursor. Subsequent based 
mediated hydrolysis forms the sulfonates.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 236 
 
 
 
Figure 4.9: Azasilines can accommodate multiple modifications simultaneously. 
Modifications and their effects are labeled in color and below the structure, respectively. 
Azetidines (red) increase quantum yield, azido groups (blue) allow participation in Click 
Chemistry, and sulfonates (green) maximize aqueous solubility. 
 
 
 
 
ASiFluor730 displayed higher cytotoxicity than Oxazine 1 in HeLa cells. Lipophilic 
cationic dyes are attracted to and accumulate in the mitochondria. Cationic dyes such as 
Rhodamine 123 can also depolarize the mitochondria and induce cytotoxicity.129 Given 
the high reduction potential of azasilines, exemplified by the azatidenyl azasiline’s 
recalcitrance to oxidation, toxicity could be caused from depolarization of the 
mitochondria. Thus, appending negatively charged polar groups such as sulfonates may 
improve solubility and lower cytotoxicity.  
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In addition to their use as imaging probes, azasilines have functionality in a variety 
of biological and medical applications. For example, azasilines could be modified into 
quenchers to participate in FRET experiments, or photosensitizers that deliberately 
release ROS to participate in photodynamic therapy (PDT).6,130 Like their imaging probe 
counterparts, the long adsorption wavelength enables deep tissue applications of the 
azasiline based quenchers and photosensitizers. 
 
In summary, the main focus of my work has been to increase the utility of NIR 
fluorophores and to develop compact, photostable NIR probes. The employment of 
RLPGs extends the applications of sulfonated molecules to living cells. In CHAPTER 
II, I introduced two RLPGs capable of delivering sulfonated molecules across the cellular 
membrane of live cells. My MeSSTFMB and MeSSTFMP allow for the slow and rapid 
release of sulfonates, respectively. Compared to the reported AcOTFMB, my RLPGs 
were notably less cytotoxic, emphasizing their potential as intracellular delivery 
scaffolds. Additionally, I aimed to address the flaws of current NIR fluorophores, namely 
size and photostability. In CHAPTER III, I introduced synthetic methods to access 
novel NIR azasiline fluorophores. More importantly, I have shown that large 
bathochromic shift witnessed from oxygen to silicon substitution isn’t exclusive to 
rhodamines, opening the possibility for the design of other long emitting silylated 
luminescent probes. ASiFluor730 was compact, photostable, and fluoresces beyond 730 
nm. Nonetheless, the potential of these molecules has not been fully realized. With 
further optimization in both structural design and synthetic methods, I foresee these tools 
will play a pivotal role in illuminating the deep mysteries of biology, in cells and beyond. 
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Conjugation of MeSSTFMP to NIR Fluorophores 
 
After the synthesis of MeSSTFMP, I made tremendous efforts to append it onto NIR 
fluorophores, namely, oxazine and sulfo-Cy5. AcOTFMB protected oxazine had been 
reported, and cyanines are widely used as imaging agents.72,122  I first attempted to access 
the MeSSTFMP protected oxazines using a scheme modeled after AcOTFMB protection 
(Scheme A1).  
 
 
Scheme A1: MeSSTFMP is labile to iodide. Reagent and conditions: (a) MeSSTFMP 
(2.12), TEA, DCM, 0 °C; MeSSTFMP; (b) NaI, acetone, reflux. 
 
 
 
 
 MeSSTFMP was treated with 3-chloropropane-1-sulfonyl chloride to form the 
sulfonate ester A.1. However, iodination under Finkelstein conditions deprotected the 
sulfonate, presumably due to nucleophilic attack on the disulfide by iodide. I 
circumvented this issue by installing an iodine group on the terminal carbon prior to 
esterification (Scheme A.2). 1,3-Propanesultone was treated with sodium iodide to yield 
3-iodopropane-1-sulfonate A.2, which was subsequently chlorinated with oxalyl chloride 
to yield the sulfonyl chloride A.3. Esterification with MeSSTFMP afforded the protected 
sulfonate A.4. However, reaction with tetrahydroquinoline afforded an unexpected C-
alkylated product A.5, instead of the desired N-alkylated product. 
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Scheme A2: MeSSTFMP ester forms adduct with methoxy tetrahydroquinoline. 
Reagent and conditions: (a) NaI, acetone, reflux; (b) Oxalyl chloride, toluene, Na2SO4, 
DMF, 0 °C; (c) MeSSTFMP (2.12), TEA, DCM, 0 °C; (d) 7-methoxy-1,2,3,4-
tetrahydroquinoline, DMF, K2CO3, 65 °C. 
 
 
 
 
 The para position of aniline derivatives is nucleophilic, which drives oxazine 
cyclization (CHAPTER III). Interestingly, the tetrahydroquinoline did not attack the 
disulfide, but instead attacked the α-carbon of the sulfonate ester, leaving the disulfide 
intact.  These results suggest that the chemical reactivity of MeSSTFMP is distinct from 
TFMB derivatives.  
 
Sulfonyl fluorides have been shown to replace sulfonyl chlorides in sulfonamide and 
sulfonate ester synthesis.131 Unlike sulfonyl chlorides, sulfonyl fluorides are less prone to 
hydrolysis and thus, can be installed at the beginning of the synthesis. To integrate 
sulfonyl fluorides into our scheme, I prepared the sulfonyl fluoride A.6, as reported, and 
subsequently attached it to the two tetrahydroquinoline derivatives to yield A.7 and 
A.8.131 A diazonitrobenzene moiety was installed on A.7 to yield A.9. Acid-mediated 
 241 
 
 
cyclization between A.8 and A.9, followed by HPLC purification afforded the sulfonyl 
fluoride oxazine derivative A.10. For convenience, and as a pilot study, I attempted to 
append TFMB to the oxazine to yield A.11.131 Regrettably, esterification using reported 
conditions did not yield appreciable amounts of desired product (Scheme A3). Like 
sulfonyl chlorides, sulfonyl fluorides can form sulfene intermediaries under basic 
conditions, which are prone to hydrolysis and may explain the low yield. 131–133   
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Scheme A3: Synthesis of MeSSTFMP protected oxazine via sulfonyl fluorides. 
Reagent and conditions: (a) HF2K, pH 3 buffer, THF; (b) C10H13NO, MgO, H2O, THF, 
35 °C; (c) C15H25NOSi, MgO, H2O, THF 35 °C; (d) 4-Nitrobenzenediazonium 
tetrafluoroborate, MeOH, 10% H2SO4; (e) conc. HCl, EtOH, 80 °C; (f) TMS-TFMB 
(A.14), DBU, ACN.  
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Unlike oxazines, the synthesis of sulfo-Cy5 does not require column purification, 
which is ideal for optimizing esterification conditions. The sulfo-Cy5 was prepared as 
reported.93 Chlorination with phosphorous oxychloride (POCl3) afforded the bis-
chlorinated Cy5 A.12. Unfortunately, esterification using DABCO in dichloromethane 
generally afforded the mono-sulfonate ester with trivial amounts the desired bis-
MeSSTFMP Cy5 A.12. Through several rounds of optimizations, A.13 was finally 
synthesized with newly prepared A.12 in anhydrous dichloromethane and anhydrous 
DABCO solution. Although successful, our esterification conditions remain inefficient 
(7% yield), underlining the necessity for further optimization. 
 
 
 
 
Scheme A4: Synthesis of MeSSTFMP-protected sulfo-Cy5. Reagent and conditions: 
(a) POCl3, BTAC, ACN, reflux; (b) MeSSTFMP (2.12), DABCO, DCM, 0 °C. 
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Identification of Cuticle Permeable Scaffolds in C. elegans 
 
Nematodes are responsible for many diseases in human and livestock and remain an 
economic burden in many third world countries. For example, according to the Centers 
for Disease Control (CDC), approximately 123 million people, mainly in Africa, are 
infected with O. volvulus, the causative agent of river blindness. Currently, 
approximately 300,000 people are blinded and another 800,000 visually impaired by the 
disease.134 While the life cycle of parasitic nematodes vary, their cuticle composition is 
largely evolutionarily conserved.135–138 Using C. elegans, a free-living nematode, as a 
model for parasitic nematodes, I aimed to identify cuticle permeable scaffolds for the 
design of broad-spectrum anthelmintics. 
 
To rapidly identify cuticle permeable scaffolds, I designed a high throughput screen 
(HTS) using live C. elegans. Our screen utilized an ATP dependent bioluminescent 
reaction to measure intracellular ATP concentrations. Since the generation and 
maintenance of ATP levels represent a complex network, involving multiple pathways 
and multiple enzymes, I hypothesized that this screening approach would yield inhibitors 
from different structural classes and thus, a diverse set of cuticle permeable structural 
features.  
 
C. elegans strain PE254, that constitutively and ubiquitously expresses firefly 
luciferase was cultured and synchronized at the L1 stage using standard methods. Using a 
fluid dispenser, the L1 larvae were seeded into 96 well plates and allowed to mature into 
the L4 larval stage in the presence of the bacteria. The L4 larva displays a recognizable 
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vulva morphology (white spot) and thus, was selected for staging purposes.139 The 
uniformity of worm distribution was evaluated based on the variation (% CV) in 
bioluminescence signals after the addition of D-luciferin (Eq. Al). High variation in the 
background population increases the noise, which, in turn ,decreases the Z', which is a 
statistical estimate of signal to noise ratio in an HTS (Eq. A2).140 A perfect assay without 
any noise will have a Z' of 1. Ideally, an excellent chemical screen will have a Z' of 0.7 or 
above.140  
 
Our initial results showed poor signal distribution within plates and inconsistent 
average signal values between plates. The firefly luciferase gene is integrated into the 
genome of PE254, thus I predicted that the poor signal distribution was the direct result 
of poor worm distribution. To visualize the worm distribution under a microscope, clear 
96 well plates were seeded under identical conditions. As predicted, the worm count was 
inconsistent between wells. 
 
Sporadic worm distribution could be due to either inadequate worm mixing in the 
reservoir and/ or worm adhesion to plastic tubing during seeding.141,142   To address these 
issues, I optimized several parameters, including mix speed, size of stir bar and flask, and 
the addition of PEG-3000 to prevent adhesion. Although substantial improvements were 
made, the variation in the background signal remained unsatisfactory. Using Eq. A3, 
which assumes low signal variation from hit compounds, the Z' was estimated to be at 
most 0.58. For this reason, I did not proceed with the screen. However, I believe this 
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bioluminescence screen holds great potential for identifying diverse cuticle permeable 
scaffolds for the design of novel of broad-spectrum anthelmintics.  
 
% CV =
σn
μn 
  [Eq. A1] 
 
Z′ = 1 −
3(σp+σn)
|μp−μn| 
 [Eq. A2] 
 
Z′ = 1 −
3(σn)
|μn| 
  [Eq. A3] 
 
Eq A1 – A3: Equation to for % CV and Z' calculation. σ and μ are the standard 
deviation and average signal of the hit compounds (p) and background population (n).  
 
 
 
 
  
Plate Avg S.D % CV 
Z' 
estimate 
1 5732.917 810.863 0.14144 0.58 
2 5825.417 695.3226 0.11936 0.64 
3 4736.667 769.6926 0.162497 0.51 
 
Figure A1: Sporadic worm distribution lowers the Z'. Well number is plotted against 
its bioluminescence signal. % CV and Z' estimate are calculated with eq. A1 and eq. A3, 
respectively. 
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Materials and Methods 
 
General:  
 
Commercially available products were used without purification and purchased form 
Combi-Block, Chem-Impex, Sigma-Aldrich, Acros or Oakwood Chemicals. Palladium 
catalysts and ligands were purchased from Combi-Blocks and Chem-Impex. Anhydrous 
solvents were purchased from Acros.  Compounds were purified with the CombiFlash 
Rf+ system and HPLC-grade ChromoSolv solvents were purchased from Sigma-Aldrich.  
 
All NMR spectra (1H, 19F, and 13C) were obtained on a Bruker Ascend 500. 
Analytical HPLC was performed on an Agilent 1100 equipped with a Zorbex C8 column 
and a PDA detector (G1315A DAD). Preparatory HPLC was performed on a Varian 
ProStar equipped with Aglient 10-Prep C18 21.2 x 250 mm Column. High resolution 
mass-spec data were obtained on an Agilent 6520 Q-TOF. C elegans were dispensed with 
aBioTek MultiFlo FX microplate dispenser and read with an EnVision plate reader. Data 
were graphed and fitted using Graphpad Prism 7. NMR spectra were analyzed with 
MestReNova. 
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Bacterial culture: 
 
 
Single colonies of OP50-GFP were picked and cultured in LB broth containing 50 
μg/ml carbenicillin at 37 °C overnight. The bacteria was precipitated via centrifugation at 
6000 x g for 15 minutes and diluted in S Medium (1g/ mL). Newly grown bacteria was 
used for each experiment. 
 
Worm Culture: 
 
 
A mixed population of PE254 (feIs4) was disinfected and synchronized using 
standard sodium hydroxide/ sodium hypochlorite solution. The population was allowed to 
mature on NGM plates containing OP50-GFP. Highly fluorescent roller L4 worms were 
transferred to fresh NGM agar plates containing OP50-GFP, where they matured and laid 
eggs. Once the progeny has become adults, their eggs were harvested using the 
synchronization method. The eggs were allowed to hatch and the population was 
synchronized to L1 in M9 media overnight. The L1s were washed with S Medium 
containing 0.25 % PEG 3000 three times via centrifugation/ aspiration.  The worms were 
diluted to 3 worms per microliter, followed by OP50-GFP addition to a final 
concentration of 3 mg/ mL. 
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Plating 
 
The worm solution (100 µL was mixed continuously with a stir bar and seeded into 
96 wells white plates using a BioTek MultiFlo FX with a peristaltic pump. Once the 
seeding is completed, the plates were sealed with a breathable film and placed in a 20 °C 
incubator for 48 hours.143 
 
Bioluminescence Reading 
 
 
D-luciferin (2 µL of 500 µM stock) was added to each well using BioTek MultiFlo 
FX. The solution was allowed to equilibrate for 15 minutes, then read using the EnVision 
plate reader equipped with an ultra-sensitive luminescence cube. 
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Synthetic Methods 
 
 
 
2,2,2-trifluoro-1-(5-(methyldisulfanyl)pyridin-2-yl)ethyl 3-chloropropane-1-
sulfonate (A.1) 
 
In a 25 mL round bottom flask, compound 2.11 (41 mg, 0.2 mmol) and TEA (41 mg, 
0.4 mmol) were dissolved in anhydrous DCM (3 mL) at 0°C. 3-Chloropropanesulfonyl 
chloride (71 mg, 0.4 mmol) was separately dissolved in DCM (1 mL) and added drop-
wise to the reaction. The reaction was stirred at 0 °C for 2 hours and then poured in to aq. 
1M HCl (20 mL). The product was extracted with DCM (3 x 20 mL) and the combined 
organic layers was washed with saturated NaHCO3 (20 mL), brine (20 mL), then dried 
over Na2SO4. The solvent was removed under reduced pressure and the product was 
purified by silica gel chromatography (0-20% EtOAc/hex) to afford a pale yellow oil (69 
mg, 0.17 mmol, 87%). 1H NMR (400 MHz, CDCl3) δ 8.73 (dd, J = 2.4, 0.7 Hz, 1H), 8.02 
(dd, J = 8.3, 2.4 Hz, 1H), 7.59 (d, J = 8.3 Hz, 1H), 6.00 (q, J = 6.2 Hz, 1H), 3.65 (t, J = 
6.0 Hz, 2H), 3.45 – 3.37 (m, 2H), 2.49 (s,3H), 2.37 - 2.29 (m, 2H). 19F NMR (376 MHz, 
CDCl3) δ -75.01 (d, J = 6.3 Hz). 13C NMR (125 MHz, CDCl3) δ 147.8 – 147.7 (m), 
137.0, 135.6, 122.0 (q, J = 280.0 Hz), 122.9, 77.7 (q, J = 22.5 Hz), 49.5, 42.1, 26.5, 22.9. 
HR-EIMS m/z calculated for C11H14ClF3NO3S3+: 395.9771, found: 395.9755. 
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3-Iodopropane-1-sulfonate sodium salt (A.2) 
 
In a 100 mL round bottom flask, sodium iodide (1.1 g, 7.3 mmol) and 1,3-
Propanesultone (1 g, 8.1 mmol) were dissolved in acetone (20 mL), then refluxed. After 3 
hours, the temperature was brought down to room temperature. The product was filtered 
and washed with acetone (50 mL) to afford X as a white solid (1.9 g, 7.0 mmol, 96%) 1H 
NMR (500 MHz, MeOD) δ 3.39 (t, J = 7.0 Hz, 2H), 2.94 – 2.89 (m, 2H), 2.33 – 2.26 (m, 
2H). 13C NMR (126 MHz, MeOD) δ 49.6, 27.1, 1.4. ES-HRMS calcd for C3H6IO3S [M-
Na]-: 248.9088, found: 248.9079.  
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3-iodopropane-1-sulfonyl chloride (A.3) 
 
 
In a 25 mL round bottom flask, A.2 (200 mg, 0.76 mmol), Na2SO4 (162 mg, 1.14 
mmol) and DMF (cat.) were dissolved in toluene (4 mL) at 0 °C. Oxalyl chloride (106 
mg, 0.84 mmol) were added dropwise and the reaction was brought to temperature. After 
1 hour, the suspension was filtered and the solid was washed with ethyl acetate (3 X 5 
mL). The solvents were removed under reduced pressure to give a yellow oil (40 mg, 
0.15 mmol, 20%). The compound was used without further purification. 1H NMR (500 
MHz, CDCl3) δ 3.76 (t, J = 7.5 Hz, 2H), 3.27 (t, J = 6.5 Hz, 4H), 2.52 – 2.43 (m, 2H). 13C 
NMR (126 MHz, CDCl3) δ 65.8, 28.0, 0.9. 
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2,2,2-trifluoro-1-(5-(methyldisulfaneyl)pyridin-2-yl)ethyl 3-iodopropane-1-sulfonate 
(A.4) 
 
In a 25 mL round bottom flask, compound A.3 (171 mg, 0.64 mmol), compound 
2.11 (122 mg, 0.58 mmol) were dissolved in anhydrous dichloromethane at 0 °C. 
Triethylamine (117 mg, 1.16 mmol) was then added dropwise. After 6 hours, the reaction 
mixture was poured in aq. 1M HCl (10 mL) and extracted with ethyl acetate (3 X 10 mL). 
The combined organic layers were washed with H2O (3 X 10 mL) and brine (10 mL), 
then dried over sodium sulfate. The solvent was removed under reduced pressure and the 
product was purified by silica gel chromatography (0-20% EtOAC /hexanes) to afford a 
yellow oil (185 mg, 0.46 mmol, 80%). 1H NMR (500 MHz, CDCl3) δ 8.73 (d, J = 2.3 Hz, 
1H), 7.99 (dd, J = 8.3, 2.3 Hz, 1H), 7.56 (d, J = 8.3 Hz, 1H), 5.93 (q, J = 6.2 Hz, 1H), 
3.33 (t, J = 7.5 Hz, 2H), 3.25 (t, J = 6.6 Hz, 2H), 2.49 (s, 3H), 2.38 – 2.31 (m, 2H). 19F 
NMR (471 MHz, CDCl3) δ -74.95 (d, J = 6.2 Hz). 13C NMR (126 MHz, CDCl3) δ 
147.96, 147.86, 137.11, 135.71, 123.0 (d, J = 0.8 Hz), 122.1 (d, J = 280.4 Hz), 77.9 (d, J 
= 33.9 Hz), 52.9, 27.1, 23.1, 2.0. ES-HRMS calcd for C11H14F3INO3S3: 487.9127, 
found: 487.9115. 
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7-methoxy-6-(2,2,2-trifluoro-1-(5-(methyldisulfaneyl)pyridin-2-yl)ethyl)-1,2,3,4-
tetrahydroquinoline (A.5) 
 
In a 10 mL round bottom flask, compounds A.11 (49 mg, 0.1 mmol), 7-methoxy-
1,2,3,4-tetrahydroquinoline (19 mg, 0.12 mmol) and potassium carbonate (17 mg, 0.12 
mmol) were dissolved in DMF (2 mL), then the temperature was raised to 65 °C. After 3 
hours the reaction was poured in to brine (20 mL) and extracted with ethyl acetate (3 X 
10 mL). The combined organic layers were washed with H2O (3 X 10 mL) and brine (10 
mL), then dried over sodium sulfate. The solvent was removed under reduced pressure 
and the product was purified by silica gel chromatography (0-30% EtOAC /hexanes) to 
afford a yellow oil (30 mg, 0.75 mmol, 75%).1H NMR (500 MHz, CDCl3) δ 8.69 (dd, J = 
2.3, 0.4 Hz, 1H), 7.80 (dd, J = 8.2, 2.5 Hz, 1H), 7.33 (d, J = 8.2 Hz, 1H), 7.10 (s, 1H), 
6.00 (s, 1H), 5.38 (q, J = 10.1 Hz, 1H), 3.74 (s, 3H), 3.31 – 3.21 (m, 2H), 2.77 – 2.59 (m, 
2H), 2.45 (s, 3H), 1.95 – 1.83 (m, 3H). 19F NMR (471 MHz, CDCl3) δ -65.74 (d, J = 10.2 
Hz). 13C NMR (126 MHz, CDCl3) δ 156.4, 155.4 – 155.3 (m), 148.7, 145.6, 136.4, 132.8, 
130.5, 126.3 (q, J = 281.1 Hz), 124.2 – 124.0 (m), 114.0, 110.8, 97.1, 56.0, 47.7 (q, J = 
27.7 Hz), 41.9, 26.4, 23.1, 22.3. ES-HRMS calcd for C18H20F3N2OS2: 401.0964, 
found: 401.0953.  
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2-chloroethane-1-sulfonyl fluoride (A.6) 
 
In a 50 ml round bottom flash, 2-chloroethyl sulfonyl chloride (2g, 12.7 mmol) was 
dissolved (1 mL). Potassium bifluoride (2g, 25.4 mmol) was separately dissolved in 0.1M 
pH 3 sodium acetate buffer (9 mL) and slowly added to the reaction. After 5 hours, the 
product was extracted with diethyl ether (3 X 20 mL). The combined organic layers were 
washed with H2O (3 X 20 mL) and brine (20 mL), then dried over sodium sulfate. The 
solvent was removed under reduced pressure and the product to afford a brown oil (1.4 g, 
9.65 mmol, 76%). NMR matches previously reported.131 
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2-(7-methoxy-3,4-dihydroquinolin-1(2H)-yl)ethane-1-sulfonyl fluoride (A.7) 
 
In a 10 mL round bottom flask, 7-methoxy-1,2,3,4-tetrahydroquinoline (300 mg, 1.8 
mmol), compound A.6 (390 mg, 2.7 mmol) and magnesium oxide (108 mg, 2.7 mmol) 
were dissolved in H2O/THF (0.4/ 3.6 mL) mixture at 35 °C.  After 5 hours, the product 
was extracted with ethyl acetate (3 X 20 mL). The combined organic layers were washed 
with H2O (3 X 20 mL) and brine (20 mL), then dried over sodium sulfate. The solvent 
was removed under reduced pressure and the product was purified by silica gel 
chromatography (0-20% EtOAC /hexanes) to afford a yellow solid (360 mg, 1.32 mmol, 
73%). 1H NMR (500 MHz, CDCl3) δ 6.91 (d, J = 8.2 Hz, 1H), 6.27 (dd, J = 8.2, 1.8 Hz, 
1H), 6.14 (s, 1H), 3.89 (t, J = 6.5 Hz, 2H), 3.77 (s, 3H), 3.65 (dt, J = 6.5, 5.1 Hz, 2H), 
3.32 (t, J = 5.5 Hz, 2H), 2.71 (t, J = 6.4 Hz, 2H), 2.02 – 1.91 (m, 2H). 13C NMR (126 
MHz, CDCl3) δ 159.4, 143.9, 130.3, 116.1, 101.8, 97.4, 55.2, 49.8, 47.0 (d, J = 13.6 Hz) 
45.7, 26.9, 22.3. ES-HRMS calcd for C12H17FNO3S: 274.0908, found: 274.0896.  
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2-(7-((tert-butyldimethylsilyl)oxy)-3,4-dihydroquinolin-1(2H)-yl)ethane-1-sulfonyl 
fluoride (A.8) 
 
In a 10 mL round bottom flask, 7-((tert-butyldimethylsilyl)oxy)-1,2,3,4-
tetrahydroquinoline (300 mg, 1.3 mmol), compound A.6 (261 mg, 1.8 mmol) and 
magnesium oxide (72 mg, 1.8 mmol) were dissolved in H2O/THF (0.4/ 3.6 mL) mixture 
at 35 °C.  After 5 hours, the product was extracted with ethyl acetate (3 X 20 mL). The 
combined organic layers were washed with H2O (3 X 20 mL) and brine (20 mL), then 
dried over sodium sulfate. The solvent was removed under reduced pressure and the 
product was purified by silica gel chromatography (0-10% EtOAC /hexanes) to afford a 
yellow solid (330 mg, 0.88 mmol, 68%). 1H NMR (500 MHz, CDCl3) δ 6.82 (d, J = 8.0 
Hz, 1H), 6.19 (d, J = 8.1 Hz, 1H), 6.05 (s, 1H), 3.85 (t, J = 6.5 Hz, 2H), 3.66 – 3.55 (m, 
2H), 3.29 (t, 2H), 2.68 (t, J = 6.3 Hz, 2H), 2.01 – 1.85 (m, 2H), 0.98 (s, 9H), 0.20 (s, 6H). 
13C NMR (126 MHz, CDCl3) δ 155.2, 143.7, 130.2, 116.4, 109.2, 102.7, 49.7, 46.8 (d, J 
= 13.5 Hz), 45.7, 27.0, 25.7, 22.3, 18.2, -4.4. ES-HRMS calcd for C17H29FNO3SSi: 
374.1616, found: 274.1602.  
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(E)-2-(7-methoxy-6-((4-nitrophenyl)diazenyl)-3,4-dihydroquinolin-1(2H)-yl)ethane-
1-sulfonyl fluoride (A.9) 
 
In 50 mL round bottom flask, compound A.7 (130 mg, 0.47 mmol) was dissolved in 
methanol (4.7 mL). 4-Nitrobenzenediazonium tetrafluoroborate (123 mg, 0.52 mmol) 
was separately suspended in aq. 10% H2SO4 and added to the reaction. After 1 hour, the 
reaction was poured into sat. NaHCO3 (50 mL) and extracted with ethyl acetate (3 X 20 
mL). The combined organic layers were washed with H2O (3 X 20 mL) and brine (20 
mL), then dried over sodium sulfate. The solvent was removed under reduced pressure 
and the product was purified by silica gel chromatography (0-100% EtOAC /hexanes) to 
afford a shiny purple solid (190 mg, 0.45 mmol, 96%). 1H NMR (500 MHz, DMSO) δ 
8.34 (d, J = 8.3 Hz, 2H), 7.85 (d, J = 8.4 Hz, 2H), 7.49 (s, 1H), 6.32 (s, 1H), 4.39 (dd, J = 
12.3, 6.1 Hz, 2H), 4.04 (t, J = 6.5 Hz, 2H), 3.98 (s, 3H), 3.50 – 3.43 (m, 2H), 2.67 (t, J = 
6.0 Hz, 2H), 1.92 – 1.81 (m, 2H). 13C NMR (126 MHz, DMSO) δ 160.1, 157.3, 150.9, 
146.7, 133.6, 125.4, 122.7, 117.0, 116.6, 94.6, 56.3, 49.7, 47.5 (d, J = 11.8 Hz), 45.6, 
26.9, 21.8. ES-HRMS calcd for C18H20FN4O5S: 423.1133, found: 274.1123.  
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1,11-bis(2-(fluorosulfonyl)ethyl)-3,4,8,9,10,11-hexahydro-2H-dipyrido[3,2-b:2',3'-
i]phenoxazin-1-ium (A.10) 
 
In a 25 mL round bottom flask, compound A.7 (112 mg, 0.27) and A.8 Y (100 mg, 
0.27 mmol) were dissolved in concentrated HCl (1 mL) and ethanol (9 mL), then the 
temperature was raised to 80 °C. After 3 hours, the product was first purified by silica gel 
chromatography (0-10% MeOH/DCM), then followed by HPLC (0.1% TFA, 0-100% 
ACN/H2O) to afford compound X as a blue solid (10 mg, 0.02 mmol, 7%).1H NMR (500 
MHz, MeOD) δ 7.67 (t, J = 1.2 Hz, 2H), 7.06 (s, 2H), 4.36 – 4.23 (m, 8H), 3.80 (t, J = 
6.0 Hz, 4H), 3.02 (t, J = 5.9 Hz, 4H), 2.15 – 2.06 (m, 4H).13C NMR (126 MHz, MeOD) δ 
156.2, 150.1, 136.4, 132.4, 131.3, 96.8, 52.3, 47.9, 47.8 (d, J = 16.4 Hz), 28.4, 21.7. ES-
HRMS calcd for C22H24F2N3O5S2: 512.1120, found: 512.1107.  
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5-(chlorosulfonyl)-2-((1E,3E)-5-((E)-5-(chlorosulfonyl)-1-ethyl-3,3-dimethylindolin-
2-ylidene)penta-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indol-1-ium (A.12) 
 
In a 3 neck flask equipped with a reflux condenser, sulfo-Cy5 potassium salt (65 mg, 
0.1 mmol) and benzyltrimethylammonium chloride (BTAC) (91 mg, 0.4 mmol) was 
dissolved in anhydrous acetonitrile (6.5 mL). Phosphorous oxychloride (POCl3) (396, 2.4 
mmol) was injected via syringe and the reaction was refluxed 85 °C for 12 minutes. The 
reaction mixture was cooled to room temperature, transferred to a 100 mL round bottom 
flask and removed under reduced pressure. The residue was dissolved in cold CHCl3 (20 
mL), poured into ice water (50 mL) extracted with cold CHCl3 (2X, 20 mL). The 
combined organic layers were washed with cold brine and dried over sodium sulfate. The 
solvent was removed under reduced pressure to yield X as a blue solid (30 mg, 0.041 
mmol, 41%). The compound was used without further purification.    
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1-ethyl-2-((1E,3E)-5-((E)-1-ethyl-3,3-dimethyl-5-((2,2,2-trifluoro-1-(5-
(methyldisulfaneyl)pyridin-2-yl)ethoxy)sulfonyl)indolin-2-ylidene)penta-1,3-dien-1-
yl)-3,3-dimethyl-5-((2,2,2-trifluoro-1-(5-(methyldisulfaneyl)pyridin-2-
yl)ethoxy)sulfonyl)-3H-indol-1-ium (A.13) 
 
 
In a 100 mL round bottom flask, A.12 (30 mg, 0.041 mmol) and 2.11 (31 mg, 0.92 
mmol) were dissolved in anhydrous DCM that was dried under molecular sieves (3 Å) 
overnight, under argon atmosphere. The temperature was lowered to 0 °C and 1M 
DABCO in THF solution (82 µL, 0.082 mmol) was added dropwise. The reaction was 
allowed to warm to room temperature naturally in the ice bath and stirred for 16 hours. 
The reaction was poured into brine (20 mL) and extracted with DCM (3X, 20 mL). The 
combined organic layers were washed with H2O (3 X 20 mL) and brine (20 mL), then 
dried over sodium sulfate. The solvent was removed under reduced pressure and the 
product was purified by silica gel chromatography (0-50% MeOH /DCM), followed by 
preparatory HPLC (0.1% TFA, 0-100% ACN/H2O) to afford A.12 as a blue solid (3.2 
mg, 0.03 mmol, 7%).  1H NMR (500 MHz, MeOD) δ 8.46 (dd, J = 2.4, 0.6 Hz, 2H), 8.37 
(t, J = 13.1 Hz, 2H), 7.86 (m, 6H), 7.42 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.4 Hz, 2H), 6.74 
(t, J = 12.4 Hz, 1H), 6.40 (d, J = 13.7 Hz, 2H), 6.00 (q, J = 6.3 Hz, 2H), 4.11 (q, J = 7.2 
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Hz, 4H), 2.41 (s, 6H), 1.66 (d, J = 5.9 Hz, 12H), 1.32 (t, J = 7.2 Hz, 6H).19F NMR (471 
MHz, MeOD) δ -76.98 (d, J = 6.4 Hz).13C NMR (126 MHz, MeOD) δ 174.2, 156.7, 
147.4, 146.8, 146.5, 142.4, 136.8, 135.1, 131.2, 130.2, 128.1, 123.6, 122.2 (q, J = 281.0 
Hz), 110.9, 105.0, 77.9 (q, J = 34.0 Hz) 49.2, 39.1, 26.2, 26.1, 21.8, 11.1. ES-HRMS 
calcd for C45H47F6N4O6S6+: 1045.1719, found: 1045.1671.  
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Trimethyl(2,2,2-trifluoro-1-phenylethyl)silane (A.14) 
 
In a 50 mL round bottom flask, benzaldehyde (1 g, 9.4 mmol) and 
trimethyl(trifluoromethyl)silane (1 g, 11.3 mmol) were dissolved in anhydrous THF (20 
mL) under argon. The temperature was lowered to 0 °C, followed by the dropwise 
addition of 1 M TBAF in THF (50 µL, 0.05 mmol). The reaction was raised to room 
temperature and stirred for 30 minutes. The solvent was removed under reduced pressure 
and the product was purified by silica gel chromatography (0 – 5% EtOAc/hex) to afford 
a pale yellow oil (1.9 g, 8.2 mmol, 87%). 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.31 (m, 
2H), 7.27 – 7.22 (m, 3H), 4.80 (q, J = 6.6 Hz, 1H), -0.00 (s, 9H). 19F NMR (471 MHz, 
CDCl3) δ -78.40 (d, J = 6.7 Hz). 13C NMR (126 MHz, CDCl3) δ 135.8, 129.4, 128.6, 
127.9, 124.6 (d, J = 282.2 Hz), 73.7 (q, J = 32.1 Hz), -0.0.  
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NMR Spectra 
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